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ABSTRACT 
Fecundity, defined as the biologic capacity for reproduction, is measured 
operationally as time-to-pregnancy (TTP) among non-contracepting couples.  While most 
couples conceive naturally within six menstrual cycles of trying, 10-24% of couples take 
longer than six cycles.  Fecundity impairments are associated with long-term adverse 
health consequences including insulin resistance and gynecologic cancers, can cause 
substantial psychological and economic hardship, and cost over $5 billion annually in the 
U.S.  Therefore, identifying risk factors for subfecundity in order to increase the chances 
of natural conception among pregnancy planners is an important public health goal.  
Environmental and psychosocial risk factors are understudied in relation to reproductive 
health.  The goal of this dissertation is to examine the independent associations between 
exposure to tetrachloroethylene, perceived stress, and cigarette smoking and 
fecundability, the per cycle probability of conception. 
In study one, we used data from a retrospective cohort study of Cape Cod women 
who were exposed to tetrachloroethylene-contaminated drinking water in the 1960s-
1980s to examine the relation between tetrachloroethylene exposure and fertility.  We 
found that women with the highest modeled tetrachloroethylene exposure around the time 
		 vi 
of the pregnancy attempt had increased risk of TTP>12 months compared with 
unexposed women.  Cumulative exposure, however, was not associated with elevated risk 
of TTP>12 months.  
Studies two and three used data from Pregnancy Study Online (PRESTO), a 
preconception cohort study of pregnancy planners from North America.  In study two, we 
found that perceived stress levels in women, but not their male partners, were associated 
with lower fecundability, with little evidence of mediation by measured behavioral 
factors.  In study three, we found that male current active smoking was associated with 
lower fecundability.  In women, current smoking was only associated with reduced 
fecundability among women who smoked with high intensity and/or long duration.  
Passive smoking was not substantially associated with fecundability in either partner, but 
women exposed in utero to high intensity smoking had lower fecundability than 
unexposed women. 
Overall, we observed weak associations between tetrachloroethylene exposure, 
perceived stress, and active smoking and fertility among pregnancy planners.  These 
findings indicate that environmental and psychosocial factors may play a role in the 
etiology of infertility.  In addition, given that these exposures are common and 
modifiable, they may be important targets for public health interventions. 
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1 INTRODUCTION 
Fecundity, defined as the biologic capacity for reproduction, is measured 
operationally as time-to-pregnancy (TTP) among non-contracepting couples.  While most 
couples conceive naturally within six menstrual cycles of trying, 10-24% experience 
conception delay (TTP>6 cycles) or infertility (TTP>12 cycles).1-4  Fecundity 
impairments are associated with long-term adverse health consequences including insulin 
resistance, metabolic syndrome, and gynecologic cancers.5-7  Infertility diagnoses can 
cause substantial psychological and economic hardship, and fertility treatments result in 
over $5 billion in annual healthcare costs in the United States.8  While fertility treatments 
have become more effective over the past decade, use of assisted reproductive 
technologies may be associated with higher risk of fetal and maternal pregnancy 
complications,9-11 birth defects,12 and infectious and chronic disease later in life.13  
Therefore, identifying risk factors for subfecundity in order to increase the chances of 
natural conception among pregnancy planners is an important public health goal. 
The physical and social environments in which individuals live have important 
implications for short- and long-term health.  Environmental exposures and psychosocial 
stressors have been associated with a vast array of health conditions14-21 and are 
hypothesized to partially explain economic and racial health disparities,22 given that low 
income and minority communities are exposed to these risk factors at higher levels.23,24  
Although environmental and psychosocial risk factors are understudied in relation to 
reproductive health, there is some evidence that these exposures may also affect 
fertility.25-28  An improved understanding of the environmental and psychosocial 
		
2 
determinants of fertility has important implications for environmental policy, health 
disparities, and lifestyle interventions for couples attempting to conceive. 	  
		
3 
1.1 REFERENCES 
1. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to 
pregnancy: results of the German prospective study and impact on the management of 
infertility. Hum Reprod 2003;18:1959-66. 
2. Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early 
pregnancy loss, and time to clinical pregnancy: a population-based prospective study. 
Fertil Steril 2003;79:577-84. 
3. Buck Louis GM, Sundaram R, Schisterman EF, et al. Heavy metals and couple 
fecundity, the LIFE Study. Chemosphere 2012;87:1201-7. 
4. Thoma ME, McLain AC, Louis JF, et al. Prevalence of infertility in the United 
States as estimated by the current duration approach and a traditional constructed 
approach. Fertil Steril 2013;99:1324-31 e1. 
5. Ventimiglia E, Capogrosso P, Boeri L, et al. Infertility as a proxy of general male 
health: results of a cross-sectional survey. Fertil Steril 2015;104:48-55. 
6. Munksgaard PS, Blaakaer J. The association between endometriosis and 
gynecological cancers and breast cancer: a review of epidemiological data. Gynecol 
Oncol 2011;123:157-63. 
7. Ollila MM, Piltonen T, Puukka K, et al. Weight Gain and Dyslipidemia in Early 
Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study. J Clin 
Endocrinol Metab 2016;101:739-47. 
8. Macaluso M, Wright-Schnapp TJ, Chandra A, et al. A public health focus on 
infertility prevention, detection, and management. Fertil Steril 2010;93:16 e1-0. 
		
4 
9. Finnstrom O, Kallen B, Lindam A, Nilsson E, Nygren KG, Olausson PO. 
Maternal and child outcome after in vitro fertilization--a review of 25 years of 
population-based data from Sweden. Acta Obstet Gynecol Scand 2011;90:494-500. 
10. Qin J, Sheng X, Wu D, et al. Adverse Obstetric Outcomes Associated With In 
Vitro Fertilization in Singleton Pregnancies. Reprod Sci 2017;24:595-608. 
11. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive 
technology, and adverse pregnancy outcomes: executive summary of a National Institute 
of Child Health and Human Development workshop. Obstet Gynecol 2007;109:967-77. 
12. Hansen M, Kurinczuk JJ, Milne E, de Klerk N, Bower C. Assisted reproductive 
technology and birth defects: a systematic review and meta-analysis. Hum Reprod 
Update 2013;19:330-53. 
13. Kettner LO, Henriksen TB, Bay B, Ramlau-Hansen CH, Kesmodel US. Assisted 
reproductive technology and somatic morbidity in childhood: a systematic review. Fertil 
Steril 2015;103:707-19. 
14. Cosselman KE, Navas-Acien A, Kaufman JD. Environmental factors in 
cardiovascular disease. Nat Rev Cardiol 2015;12:627-42. 
15. Steptoe A, Kivimaki M. Stress and cardiovascular disease. Nat Rev Cardiol 
2012;9:360-70. 
16. Prezant DJ, Levin S, Kelly KJ, Aldrich TK. Upper and lower respiratory diseases 
after occupational and environmental disasters. Mt Sinai J Med 2008;75:89-100. 
		
5 
17. Pedersen A, Zachariae R, Bovbjerg DH. Influence of psychological stress on 
upper respiratory infection--a meta-analysis of prospective studies. Psychosom Med 
2010;72:823-32. 
18. Thompson PA, Khatami M, Baglole CJ, et al. Environmental immune disruptors, 
inflammation and cancer risk. Carcinogenesis 2015;36 Suppl 1:S232-53. 
19. Shin KJ, Lee YJ, Yang YR, et al. Molecular Mechanisms Underlying 
Psychological Stress and Cancer. Curr Pharm Des 2016;22:2389-402. 
20. Wisborg K, Barklin A, Hedegaard M, Henriksen TB. Psychological stress during 
pregnancy and stillbirth: prospective study. BJOG 2008;115:882-5. 
21. Nieuwenhuijsen MJ, Dadvand P, Grellier J, Martinez D, Vrijheid M. 
Environmental risk factors of pregnancy outcomes: a summary of recent meta-analyses of 
epidemiological studies. Environ Health 2013;12:6. 
22. James-Todd TM, Chiu YH, Zota AR. Racial/ethnic disparities in environmental 
endocrine disrupting chemicals and women's reproductive health outcomes: 
epidemiological examples across the life course. Curr Epidemiol Reports 2016;3:161-80. 
23. Burris HH, Collins JW, Jr., Wright RO. Racial/ethnic disparities in preterm birth: 
clues from environmental exposures. Curr Opin Pediatr 2011;23:227-32. 
24. Strutz KL, Hogan VK, Siega-Riz AM, Suchindran CM, Halpern CT, Hussey JM. 
Preconception stress, birth weight, and birth weight disparities among US women. Am J 
Public Health 2014;104:e125-32. 
25. Buck Louis GM. Persistent environmental pollutants and couple fecundity: an 
overview. Reproduction 2014;147:R97-R104. 
		
6 
26. Frutos V, Gonzalez-Comadran M, Sola I, Jacquemin B, Carreras R, Checa 
Vizcaino MA. Impact of air pollution on fertility: a systematic review. Gynecol 
Endocrinol 2015;31:7-13. 
27. Lynch CD, Sundaram R, Maisog JM, Sweeney AM, Buck Louis GM. 
Preconception stress increases the risk of infertility: results from a couple-based 
prospective cohort study--the LIFE study. Hum Reprod 2014;29:1067-75. 
28. Meeker JD, Missmer SA, Vitonis AF, Cramer DW, Hauser R. Risk of 
spontaneous abortion in women with childhood exposure to parental cigarette smoke. Am 
J Epidemiol 2007;166:571-5. 
 
		
7 
2 EXPOSURE TO TETRACHLOROETHYLENE-CONTAMINATED DRINKING 
WATER AND TIME TO PREGNANCY 
2.1 INTRODUCTION 
 Tetrachloroethylene (perchloroethylene; PCE) is a synthetic, volatile organic 
solvent used in dry cleaning solutions, textile processing, and metal degreasing 
operations.1  The primary routes of exposure in the general population are vapor 
inhalation from conventionally dry-cleaned fabrics and contaminated soil, and ingestion 
of contaminated water.1,2  PCE distributes widely throughout the body, with the highest 
concentration in adipose tissue due to its lipophilic nature and has a half-life in the human 
body of approximately 96 days.1  PCE is a well-recognized animal and human 
neurotoxicant1 and carcinogen;3,4 however, its effects on reproduction are poorly 
understood.  In rodent studies, PCE and the related solvent trichloroethylene (TCE) have 
adversely affected fertilization5-7 and semen quality.8  Epidemiologic studies conducted 
almost exclusively among dry cleaning workers have found evidence that dry cleaning 
work or suspected occupational PCE exposure is associated with increased risk of poor 
semen quality,9-11 infertility,12,13 and longer time-to-pregnancy (TTP).14,15  
 From 1968 through 1980, many public water departments throughout New 
England installed vinyl-lined asbestos-cement (VL/AC) water pipes on an as-needed 
basis to solve taste and odor problems.  The liner was painted onto the inner surface of 
the pipes in a slurry of vinyl toluene resin (Piccotex™) and PCE.  The manufacturer 
recommended that 48 hours lapse to allow the liner to dry before shipping the pipes for 
distribution; it was assumed that most of the PCE would evaporate by the time of 
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shipment.16  However, in 1980, government officials discovered that high levels of PCE 
persisted in the liner and had been slowly leaking into the public drinking water supply 
for over a decade.  Approximately 660 miles of VL/AC pipes were installed in 
Massachusetts, with a large proportion in the Cape Cod region.17  PCE levels on Cape 
Cod ranged from 1,600-7,750 µg/L in low-flow areas and 1.5-80 µg/L in medium- and 
high-flow areas.16  Current United States Environmental Protection Agency (US EPA) 
drinking water regulations set the maximum PCE contaminant level at 5 µg/L.18  Because 
replacing the VL/AC pipes was prohibitively expensive, officials began a program of 
regular flushing and bleeding to remediate the problem in 1980.  This exposure scenario 
constitutes a type of natural experiment because the irregular installation pattern of 
VL/AC pipes resulted in neighboring households with vastly different contaminant 
levels.  Levels of other drinking water contaminants were low.19 
 In the present analysis, we examined the association between PCE exposure 
through contaminated drinking water and TTP in a cohort of women from Cape Cod who 
had successfully conceived. 
2.2 METHODS 
2.2.1 Study design and selection of study population 
The Cape Cod Family Health Study is a retrospective cohort designed to examine 
the association between exposure to PCE-contaminated drinking water and reproductive 
and developmental health.  Study methods have been described in detail elsewhere.20  
Briefly, in 2002, we identified women who gave birth from 1969-1983 while residing in a 
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Cape Cod town with documented VL/AC distribution pipes (Barnstable, Bourne, 
Falmouth, Mashpee, Sandwich, Brewster, Chatham, and Provincetown, Massachusetts).  
We visually inspected water pipe distribution maps in the vicinity of the maternal address 
at birth to identify exposed and unexposed births.  We classified 1,492 women as exposed 
because they either lived adjacent to a VL/AC pipe or the only possible water flow to the 
residence was through a VL/AC pipe.  We selected a comparison group of 1,704 
unexposed women so that their offspring were frequency-matched to those of the exposed 
women based on the birth month and year.  Initial exposure status was considered 
preliminary; we later conducted a more detailed exposure assessment, described below 
(see “PCE exposure assessment”). 
 We successfully traced 91.2% of exposed and 92.0% of unexposed women.  We 
mailed introductory letters and self-administered questionnaires to all traced participants 
from 2002-2003.  Self-administered questionnaires collected information on demographic 
characteristics, occupational exposure to solvents, use of professional or self-service dry 
cleaning, residential history, water consumption and bathing habits, medical history, and 
reproductive history, including detailed information about each of their pregnancies (live 
births, still births, miscarriages, induced abortions, and ectopic pregnancies). 
 Women initially classified as exposed and unexposed had similar response rates 
(64.3% and 63.8%).  Non-participants were younger (mean age 26.0 vs. 27.5 years), less 
educated (11.3% vs. 3.6% did not graduate from high school) and had more prior births 
(51.1% vs. 24.3% had at least three prior births) than participants, but were similar with 
respect to race (96.2% white in both groups) and year of pregnancy (54.7% vs. 56.0% 
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born from 1979-1983); these differences were observed for both exposed and unexposed 
women.20,21 
All participants provided informed consent.  The institutional review boards of 
Boston University Medical Center and the Massachusetts Department of Public Health 
approved the study protocol. 
2.2.2 Geocoding of residential addresses 
On self-administered questionnaires, women reported detailed information on 
each of their Cape Cod residences from 1969 through 1990 (the time period during which 
we assessed PCE exposure), including exact street address, nearest cross street, calendar 
years of occupancy, and drinking water source.  Throughout the study period, 29.5% of 
women did not move, whereas 31.7% of women moved once and 38.8% of women 
moved more than once.  The 5,324 reported addresses were incorporated into a 
geographic information system (GIS) using ArcGIS 8.1.  Geocoding to a latitude and 
longitude was conducted without knowledge of exposure or pregnancy history.  The 
majority of addresses were successfully geocoded to a parcel of land (87.6%) or the 
nearest reported cross street or the middle of the street in instances where street number 
was missing (9.6%).  We were unable to geocode the remaining 2.7% of addresses, and 
pregnancies associated with these addresses were excluded from the analysis. 
2.2.3 PCE exposure assessment 
We refined our PCE exposure assessment using a leaching and transport model 
developed by Webler and Brown for our prior epidemiologic studies.22,23  This model 
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estimates the amount of PCE entering the drinking water using the initial PCE loading in 
the pipe liner (estimated using the pipe dimensions), the age of the pipe, and the leaching 
rate of PCE from the pipe into the water.16  We incorporated the Webler and Brown 
algorithm into EPANET water distribution system modeling software 
(www.epa.gov/nrml/wswrd/dw/epanet.html) to account for water flow and direction, 
which are functions of the water system geometry and the number of water users.  This 
software was developed by the US EPA and simulates the instantaneous flow of water 
throughout the entire public water distribution system in a town.24  It has been used to 
assess exposure to drinking water contaminants in several epidemiologic studies.25-28 
 We created a GIS schematic, which represented the pipe configuration present 
around 1980, a year which is likely representative of the water distribution system during 
the study period.  We included water source locations, nodes (points of water 
consumption), and pipe characteristics obtained from local water companies and the 
Massachusetts Department of Environmental Protection.  The EPANET software was 
used to model the flow of water through thousands of pipe segments in order to estimate 
the quantity, or mass, of PCE delivered to each participant’s residence.  We assigned 
each geocoded residence to the closest node on the water distribution system.  We 
assumed that each residence drew the same quantity of water and that the water sources 
did not change over the study period.  We calculated annual PCE exposure for each 
woman for every year from 1949 through 1990.  Annual exposure was zero before 1969 
and during years when women lived in residences with private wells or in a town without 
documented VL/AC pipes. 
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2.2.4 Assessment of time to pregnancy 
On self-administered questionnaires, women reported how long it took for them to 
conceive each of their planned pregnancies.  Response choices were <3 months, 3-6 
months, 7-12 months, or >12 months. 
2.2.5 Covariate assessment 
We collected covariate information from self-administered questionnaires, 
including demographics (parental age at pregnancy, maternal education and paternal 
occupation at time of self-administered questionnaire, maternal race/ethnicity), medical 
history (pre-pregnancy history of pelvic inflammatory disease, uterine leiomyomata, 
ovarian cysts, endometriosis, polycystic ovarian syndrome, gonorrhea or chlamydia), 
pregnancy information (year of pregnancy, pregnancy outcome, gravidity, parity, first 
trimester smoking, first trimester alcohol use, caffeine intake during pregnancy, 
marijuana use in pregnancy, oral contraceptive use in three months before conception), 
and menstrual cycle characteristics (cycle regularity, cycle length, pre-pregnancy history 
of amenorrhea).  We did not collect data on preconception smoking or alcohol use. 
2.2.6 Exclusions 
Overall, study participants reported 6,519 pregnancies from 1949-1990.  The 
earliest exposure occurred in 1963; the amount and timing of exposure depended on 
location of residence, time residing at a particular address, and the timing of pipe 
installation on each street.  We excluded pregnancies with missing pregnancy end dates 
(mostly non-live births) or pregnancy end dates after 1990 (n=246).  We also excluded 
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pregnancies with incalculable PCE exposure, either because of missing residential move-
in or move-out years (n=249) or insufficient information to geocode addresses (n=131), 
and unplanned pregnancies (n=2,067).  The proportion of unplanned pregnancies did not 
differ substantially between exposed (33.1%) and unexposed (36.1%) women.  The final 
analytic sample included 3,826 pregnancies, including both the birth(s) that determined 
eligibility for the cohort and all other planned pregnancies, to 1,565 women.  We did not 
collect information on pregnancy attempts that did not result in a clinically-recognized 
pregnancy. 
2.2.7 Statistical analysis 
We calculated two exposure metrics for each pregnancy: cumulative exposure 
before the pregnancy attempt (hereafter “cumulative PCE exposure”) and average 
monthly exposure during the calendar year of the pregnancy attempt (hereafter “average 
monthly PCE exposure”).  Cumulative PCE exposure was calculated by summing the 
annual mass of PCE between the VL/AC pipe installation or move-in year, whichever 
came later, and the year the woman began attempting pregnancy.  We calculated average 
monthly PCE exposure by dividing the annual PCE mass for the year the woman began 
attempting pregnancy by 12.  We identified the month and year each woman began 
attempting each of her pregnancies by subtracting her reported TTP from the date of her 
last menstrual period (i.e., the beginning of her pregnancy, estimated using self-reported 
pregnancy end date and length of gestation).  Because TTP was reported in categories, for 
exposure measurement purposes, we assigned each woman a continuous TTP value based 
on the approximate midpoint of the category: 1, 4, 9, and 14 months for women who 
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reported TTP categories of <3, 3-6, 7-12, and >12 months, respectively.  We selected 
these values erring on the lower side of the midpoint based on the distribution of TTP in a 
general population of pregnancy planners.29  We conducted a sensitivity analysis 
assigning women continuous TTP values of 2, 5, 10, and 18, respectively, out of concern 
that selecting shorter TTP values (i.e., later initiation of pregnancy attempt relative to last 
menstrual period date) may overestimate cumulative exposure. 
We examined the two exposures as binary (any vs. no exposure) and categorical 
variables.  For cumulative PCE exposure, categories were based on orders of magnitude 
(no exposure (reference), >0-<10, 10-<100, and ≥100 grams); for average monthly PCE 
exposure, categories were defined based on the distribution in the data set (no exposure 
(reference), >0-<1, 1-<2.5, and ≥2.5 grams).  The outcome variable was analyzed in its 
original form (<3, 3-6, 7-12, and >12 months) and as two binary variables: TTP >12 vs. 
≤12 months and TTP>6 vs. ≤6 months.  We used log-binomial regression models to 
estimate risk ratios (RR) and 95% confidence intervals (CI).  We used generalized 
estimating equations to account for correlation of pregnancies contributed by the same 
woman.  We first examined the crude association between each PCE exposure and 
TTP>12 months, TTP>6 months, and TTP categories 3-6, 7-12, and >12 months (vs. <3 
months).   
We selected variables for inclusion in final models that changed the coefficient on 
PCE by >5% in bivariate models, including: maternal age (<25, 25-29, 30-34, ≥35 years), 
paternal age (<25, 25-29, 30-34, ≥35 years), year of pregnancy (pre-1975, 1975-1980, 
1981-1990), maternal education (<12, 12, 13-15, ≥16 years), paternal occupation (blue 
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collar, white collar, other), first trimester cigarette smoking (any, none), first trimester 
alcohol intake (any, none), and pregnancy number (1, 2, 3, 4, 5, ≥6).  To allow for the 
possibility of non-linear associations between PCE exposure and fertility, we fit restricted 
cubic splines.30,31 
 We stratified final models by maternal age (<30 vs. ≥30 years) and parity 
(nulliparous vs. parous) to assess the extent to which the relation between PCE exposure 
and delayed TTP is stronger among older or nulliparous couples, potentially less fertile 
subgroups.  We conducted a sensitivity analysis restricting to first pregnancies only, out 
of concern that pregnancies to more fertile women were overrepresented in our sample.  
Finally, we conducted a sensitivity analysis excluding pregnancies that ended after 1980, 
when flushing and bleeding began, out of concern that exposure to these pregnancies was 
more likely to be misclassified than earlier pregnancies.  
 We generated five imputation data sets using a Markov chain Monte Carlo 
method32 that assumes multivariate normality to impute missing outcome and covariate 
data.33-35  TTP data were missing for 2.4% of pregnancies.  Missingness for covariates 
ranged from 0% (gravidity, parity) to 2.5% (cycle regularity). 
 TTP may not be reported accurately, especially over long time periods of 
recall.29,36-39  Participants reported TTP for each of their pregnancies, with a median 
recall of 24 years (range 12-53 years).  To assess the effect of outcome misclassification 
on our results, we conducted a probabilistic bias analysis on all five imputation data 
sets.40  Prior analyses demonstrate that women did not know their true PCE exposure 
levels;41 therefore, we assumed that TTP misclassification was non-differential with 
		
16 
respect to exposure.  We defined trapezoidal distributions for sensitivity and specificity 
of TTP >12 months based on prior literature.38  Trapezoidal distributions specify lower 
and upper modes, between which the probability density is uniform, as well as minimum 
and maximum values, to which the probability density decreases linearly to zero.  For 
sensitivity (93% in the Jukic et al. validation study), we assigned minimum, lower mode, 
upper mode, and maximum values of 0.86, 0.88, 0.98, and 1.00, respectively; for 
specificity (96% in the Jukic et al. validation study), these values were 0.92, 0.94, 0.98, 
and 1.00, respectively.  We sampled 1,000 times from these distributions (separately for 
exposed and unexposed women, but assuming a correlation of 0.8) and converted 
sensitivity and specificity to positive and negative predictive values.  We calculated 1,000 
corrected data sets by sampling true outcome values from a binary distribution with 
probabilities of success equal to the positive and negative predictive values, and 
estimated RRs for each of these data sets.  From the distribution of correct RRs, we 
present the median, 2.5th, and 97.5th percentiles to determine the measure of central 
tendency and magnitude of bias. 
2.3 RESULTS 
 The 1,565 women in the analytic sample were mostly white (96.3%), educated 
(80.0% with some college education) and had partners working white collar jobs 
(51.2%).  Women reported 3,826 planned pregnancies between 1949 and 1990.  Overall, 
20.7% of women contributed one pregnancy to the analysis, 40.5% contributed two 
pregnancies, and 38.8% contributed three or more pregnancies (maximum=10 
pregnancies).  Mean maternal and paternal ages for all pregnancies were 26.7 (standard 
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deviation (SD)=4.7) and 29.7 (SD=5.8) years, respectively.  The prevalence of cigarette 
smoking or alcohol consumption in the first trimester was 27.1% and 37.5%, 
respectively.  Nineteen percent of women drank at least two caffeinated beverages per 
day during the pregnancy, and 3.6% smoked marijuana.  Most women reported regular or 
somewhat regular menstrual cycles (86.7%) and had cycle lengths ranging from 25-40 
days (88.7%). 
 Most study pregnancies (65.3%) took <3 months to conceive; however, 15.8%, 
7.2%, and 11.3% of pregnancies took 3-6, 7-12, and >12 months to conceive, 
respectively.  Longer TTP was positively associated with older maternal and paternal age, 
lower maternal education, non-white maternal race, first trimester cigarette smoking, 
caffeine intake during pregnancy, pre-pregnancy history of several gynecologic 
conditions (including pelvic inflammatory disease, ovarian cysts, endometriosis, and 
amenorrhea), and irregular, short (<25 days) or long (>40 days) menstrual cycles. 
Some PCE exposure occurred before 42.4% of pregnancies; only 34.2% of 
pregnancies were exposed during the year the pregnancy attempt began.  Among the 
exposed, the median (range) exposure was 26.8 grams (0.001-3,826.7) for cumulative 
PCE exposure and 0.6 grams (0.0001-84.5) for average monthly PCE exposure.  The two 
exposures were highly correlated (Spearman correlation coefficient=0.82).  On average, 
exposed women were older than unexposed women (Table 2.1).  They were also more 
likely to have births later in the study period, to have a history of pregnancy or live birth, 
and to have a history of specific gynecologic conditions, although these differences are 
likely confounded by time (i.e., cumulative exposure increases with time, as does the 
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probability of pregnancy and the risk of specific gynecologic conditions). 
 Women with any PCE exposure before the pregnancy attempt had 15% lower risk 
of TTP>12 months than unexposed women (Table 2.2).  When categorizing exposure, 
women in each of the exposed categories had a lower risk of TTP>12 months relative to 
unexposed women (for example, for cumulative PCE exposure of <10 grams vs. 
unexposed, RR=0.76, 95% CI: 0.58-1.00).  However, women with the highest average 
monthly PCE exposure had an increased risk of TTP>12 months compared with 
unexposed women (RR=1.36, 95% CI: 1.06-1.76).  In the restricted cubic spline analysis, 
risk of TTP>12 months was not substantially related to cumulative PCE exposure (Figure 
2.1), but increased approximately linearly from 2 to 4 grams for average monthly PCE 
exposure (Figure 2.2).  We did not have sufficient data to draw conclusions on risk at 
exposure levels above 4 grams.  Results were similar, but weaker, when examining risk 
of TTP>6 months (Table 2.3). 
Results were similar when we assessed TTP as a 4-level outcome (Table 2.4), 
with some evidence of an inverse relationship with cumulative PCE exposure, as well as 
a positive association between the highest level of average monthly PCE exposure and 
risk of having TTP>12 vs. <3 months (RR for ≥2.5 grams vs. unexposed=1.26, 95% CI: 
1.01, 1.58). 
 The positive association between average monthly PCE exposure and risk of 
TTP>12 months was stronger among women ≥30 years old (RR=1.60, 95% CI: 1.09, 
2.35) than among women <30 years old (RR=1.16, 95% CI: 0.81, 1.66), but was similar 
among nulliparous and parous women.  The inverse association between cumulative PCE 
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exposure and risk of TTP>12 months was stronger among women <30 years old and 
parous women (Tables 2.5 and 2.6).  When we examined the association among first 
pregnancies only (n=1,297), we found little evidence of an inverse association between 
cumulative PCE exposure and risk of TTP>12 months; the point estimate comparing 
average monthly PCE exposure of ≥2.5 grams vs. unexposed (RR=1.32, 95% CI: 0.86, 
2.04) was similar to the main analysis (RR=1.36, 95% CI: 1.06, 1.76), but results were 
less precise.  Treating TTP as a continuous variable and assigning values of 2, 5, 10, and 
18 months to each woman reporting TTP in the four ranked categories, respectively, 
resulted in a downward shift in RRs (RR comparing average monthly PCE exposure of 
≥2.5 grams with no exposure was 1.24, 95% CI: 0.95-1.62) as opposed to 1.36 from the 
main analysis.  When we restricted to pregnancies that ended before the flushing and 
bleeding began (1980), the inverse association between cumulative PCE and TTP>12 
months was slightly stronger (RR=0.79, 95% CI: 0.61, 1.01).  The positive association 
between average monthly PCE ≥2.5 grams vs. unexposed and TTP>12 months was 
weaker (RR=1.15, 95% CI: 0.82, 1.63). 
 In the probabilistic bias analysis, the median RR comparing risk of TTP>12 
months among women with any vs. no cumulative PCE exposure was 0.85, with a 95% 
simulation interval of 0.65 to 0.98 (observed RR=0.85).  The median RR comparing 
average monthly PCE exposure ≥2.5 grams with no exposure was 1.39, with a 95% 
simulation interval of 0.84 to 1.72 (observed RR=1.36).   
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2.4 DISCUSSION 
 We found little evidence for long-term, cumulative effects of PCE exposure on 
length of TTP, but PCE exposure around the time of the pregnancy attempt was 
associated with longer TTP.  The spline analysis indicated a threshold effect; associations 
between average monthly PCE exposure and risk of TTP>12 months were only present at 
exposure levels ≥2.5 grams per month.  Results were stronger among women aged ≥30 
years, but were similar for nulliparous and parous women.  Conversely, cumulative PCE 
exposure was associated with lower risk of TTP>12 months, regardless of exposure level. 
 Our finding of an increased risk of TTP >12 months among women with the 
highest average monthly exposure is consistent with studies examining TTP among 
female dry cleaning workers.  Danish women currently exposed to dry-cleaning 
chemicals had a 60% higher risk of infertility compared with unexposed women.13  
Likewise, a study of Finnish women occupationally exposed to organic solvents found 
that current dry cleaning work was associated with reduced fecundability (fecundability 
ratio (FR), the probability of pregnancy in exposed compared with unexposed 
women=0.44); FRs for low and high exposure to PCE were 0.63 and 0.69, respectively.15  
Female exposure to other volatile organic solvents, including acetone, toluene, and 
ethylene glycol ethers, has also been associated with reduced fecundability and increased 
infertility risk in occupational studies.42-48 
Studies of male exposure are relevant to the present study because our PCE 
exposure metric was based on residence, and the vast majority of couples planning a 
pregnancy reside at the same address.  Therefore, we were unable to distinguish between 
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female and male exposure and our results could reflect an association with PCE exposure 
to either sex.  Prior studies have found that male exposure to PCE or other organic 
solvents may be associated with longer TTP,12,48,49 in vitro fertilization (IVF) failure,50 
and poor semen quality.9-11  An occupational study in California found subtle changes in 
semen quality among dry cleaning workers compared with laundry workers;9 the wives of 
dry cleaning workers also had lower fecundability (FR=0.54) than the wives of laundry 
workers.12  In a study of 726 Dutch couples undergoing IVF, couples where the male was 
exposed to organic solvents had lower implantation rates than unexposed men.50  A 
Finnish study conducted as part of a biologic monitoring program of men occupationally 
exposed to organic solvents found increased TTP in first pregnancies among men with 
organic solvent exposure.14 
 The difference in results for cumulative PCE exposure and average monthly PCE 
exposure could speak to potential biologic mechanisms, if the association is causal.  
Because we observed an increased risk of longer TTP among women with the highest 
average monthly PCE exposure, but not among women with the highest cumulative 
exposure, PCE exposure around the time of conception, rather than long-term exposure, 
may be more temporally relevant.  In the short-term, PCE exposure may influence 
menstrual function, hormone levels, or sperm quality.51  It may cause an increased risk of 
early fetal loss,52-58 either by affecting implantation, placental function, or increasing risk 
of congenital anomalies.59-63  If the early fetal loss is not clinically recognized, it would 
result in an apparently longer TTP.  Our analysis of cumulative PCE exposure indicate 
that it is unlikely that long-term PCE exposure depletes ovarian reserve or harms oocyte 
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quality. 
 An unusual feature of this study design for our research question is that we only 
had information on pregnancy attempts that were successful (i.e., resulted in a clinically-
recognized pregnancy).  The Cape Cod Family Health Study was designed to examine the 
effects of prenatal PCE exposure on neonatal and childhood health, so only women who 
had a live birth during the study period were eligible, and we did not collect information 
on the timing of unsuccessful pregnancy attempts.  Conditioning on pregnancy precluded 
estimation of absolute TTP among exposed and unexposed women and therefore 
restricted our analysis to relative measures of association.  In addition, it likely resulted in 
some selection bias.  If PCE exposure does lengthen TTP, its effect would be 
underestimated in this study because the women who never conceived are not represented 
in our study population. 
 We attempted to quantify the extent of outcome misclassification on our findings 
by repeatedly sampling from sensitivity and specificity distributions defined using 
external validation data and calculating corrected RRs for each simulation.  The bias 
analysis results for cumulative PCE exposure (exposed vs. unexposed) suggest that while 
there is some uncertainty regarding the size of the association, it is unlikely that outcome 
misclassification obscured a true positive effect.  The 95% simulation interval for RR 
values ranged from 0.65 to 0.98, providing little indication that any plausible 
misclassification obscured a meaningful positive effect.  In contrast, for average monthly 
PCE exposure (≥2.5 grams vs. unexposed), the bias analysis results suggested a wide 
range of plausible true values (95% simulation interval 0.84 to 1.72), from a weak inverse 
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to a strong positive association.   
 Because individual exposure measurements at the time of each pregnancy attempt 
were not available, we relied on a leaching and transport model to estimate historical 
PCE exposures.23  To the extent that the model assumptions were incorrect, or the model 
inputs were measured with error, exposure will be misclassified as a result.  A validation 
study comparing model-based PCE exposure estimates with PCE concentrations in 
historical water samples showed reasonable correlation (Spearman correlation 
coefficient=0.65).64  The model estimates the annual amount of PCE that entered the 
residence, but does not account for individual variation in water consumption habits.  A 
previous study in this population, however, found that conducting a more detailed 
personal exposure assessment that incorporated information on bathing, showering and 
drinking habits did not substantially change the exposure ranking of subjects or measures 
of association.65  This may reflect poor recall of or lack of variability in water-related 
behaviors or may indicate that personal exposures were driven by residence, not 
behaviors.   The model also does not account for non-residential drinking water 
exposures.  Because older women may spend more time at home than younger women, 
their exposure misclassification due to non-residential sources of drinking water is likely 
lower.  This difference could explain the stronger association we observed among women 
≥30 years old compared with women <30 years old.  However, we expected the same 
pattern to hold among parous women, who also spend more time at home, but we did not 
observe differences between parous and nulliparous women in our study. 
 Exposure misclassification may also have resulted from imperfect information on 
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when women started trying to conceive.  The study collected information on TTP as a 
categorical variable, which made it difficult to identify the month women started trying to 
conceive, in particular among women who reported trying for >12 months, where the 
range of possible values is wide.  Our sensitivity analysis that converted the categorical 
variable into a continuous one, with TTP values of 2, 5, 10, and 18 for each category of 
TTP, showed that exposure estimates were relatively sensitive to our choice of 
continuous TTP.  Assigning longer continuous TTP values resulted in a downward shift 
in RRs, due to the generally lower exposures associated with beginning the pregnancy 
attempt at an earlier date.  This analysis reduced exposures for the infertile group the 
most, which explains the downward shift in RRs. 
 We did not collect information on behaviors during the preconception period that 
could affect infertility risk.  Instead, we relied on pregnancy behaviors as a proxy for 
preconception behaviors.  However, given the irregular pattern of pipe installation on 
Cape Cod, very few behavioral or demographic characteristics were associated with 
exposure, and it is unlikely that unmeasured confounding explained our results.   
 Confounding by time was likely in our analysis because pregnancies ended 
between 1949 and 1990, and both PCE exposure and TTP were correlated with time.  
Cumulative exposure, by definition, increases or stays constant over time and average 
monthly PCE exposure was 0 from 1949-1968, increased from 1969-1972, stayed 
relatively constant from 1973-1981, then decreased from 1982 onwards.  Pregnancies that 
occurred later in the study period were to women who were older and had demonstrated 
fecundity.  If the most fertile women were having pregnancies later in the study period, 
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when their cumulative exposure was highest, this could account for the observed inverse 
association between cumulative PCE exposure and longer TTP.  We attempted to control 
for these temporal patterns by adjusting for maternal age, year of pregnancy, and 
pregnancy number.  We also conducted a sensitivity analysis restricting the analytic 
sample to first pregnancies, and observed a weaker inverse association between 
cumulative PCE exposure and risk of TTP >12 months (RR=0.92 compared with 0.85 in 
the main analysis).  Residual confounding by time may have contributed to the observed 
inverse association.  We observed a similar association between the highest average 
monthly PCE exposure in all pregnancies (RR=1.36) and first pregnancies (RR=1.32). 
 Exposures were based on the annual mass of PCE that entered the home.  This 
mass was diluted in approximately 90,000 gallons of water, the average annual usage of 
households in Massachusetts.66  We observed an increased risk of TTP >12 months at 
average monthly PCE levels of ≥2.5 grams, which corresponds to average concentrations 
of approximately ≥88 µg/L for the year.  Our results indicate that adverse effects on 
fertility are unlikely to be experienced by the general population at levels below the 
current EPA regulations, but that higher levels of exposure that may occur in 
occupationally-exposed populations or from environmental contamination could lengthen 
TTP. 
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2.5 TABLES AND FIGURES 
Table 2.1 Distribution of sociodemographic, lifestyle, and pregnancy-related characteristics by PCE exposure among 
3,826 planned pregnancies 
 Cumulative PCE exposure  Average monthly PCE exposure  
  Exposed (g)  Exposed (g) 
Characteristic a Unexposed <10 10-99 ≥100 Unexposed <1.0 1.0-2.4 ≥2.5 
Number of pregnancies 2202 546 663 415 2518 798 215 295 
Maternal age (years), mean 25.7 27.5 27.8 29.2 26.2 28.1 27.3 27.3 
Paternal age (years), mean 29.5 30.3 30.1 30.5 29.5 27.0 26.9 26.9 
Year of pregnancy pre-1975, % 37.1 15.2 15.5 12.0 34.5 48.2 12.8 25.3 
Year of pregnancy, post-1980, % 26.0 45.3 37.6 44.3 29.7 48.2 26.7 23.3 
Maternal education ≤high school graduate, % 19.5 19.4 20.1 20.7 19.6 20.1 17.9 22.3 
Paternal blue collar occupation, % 29.8 32.0 35.4 31.0 30.2 33.7 36.6 28.7 
Maternal white race, % 96.6 95.6 95.6 99.1 96.7 95.2 95.9 98.5 
Any first trimester smoking, % 29.0 24.0 22.2 24.7 28.3 22.7 25.4 27.6 
Any first trimester alcohol use, % 39.1 33.9 36.8 32.8 37.8 35.5 38.4 37.0 
>2 cups/day caffeine during pregnancy, % 19.6 16.0 18.7 22.5 19.0 16.7 19.4 26.1 
Any marijuana use in pregnancy, %   3.3   3.3   4.2   3.6   3.5   4.3   2.2   3.3 
Gravid, % 61.2 71.6 74.5 76.5 63.8 73.2 71.3 68.6 
Parous, % 54.7 65.8 69.3 72.9 57.5 67.7 65.6 63.1 
Pre-pregnancy health conditions, %         
   Pelvic inflammatory disease   1.5   1.7   1.1   1.5   1.4   1.8   2.4   0.9 
   Uterine leiomyomata   3.1   3.4   3.5   4.7   3.2   3.5   4.9   3.5 
   Ovarian cysts   6.9   7.9   6.6   9.7   6.9   7.3 11.3   8.4 
   Endometriosis   3.1   3.3   4.3   4.8   3.1   4.5   4.2   3.7 
   Polycystic ovarian syndrome   0.4   1.1   0.4   0.6   0.5   0.8   0.5   0.3 
   Gonorrhea or chlamydia   1.2   1.6   1.5   0.9   1.1   1.9   2.6   0.3 
Irregular cycles, % 11.7 13.6 12.5 11.4 12.1 12.6 13.2 11.9 
Cycle length <25 days, %   8.7   9.2 13.3 11.4   9.0 11.0 14.4   7.9 
Cycle length >40 days, %   1.8   1.6   1.0   2.0   1.8   1.1   1.9   1.5 
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Pre-pregnancy amenorrhea, %   8.0   8.4   7.7   7.7   7.9   8.7 10.1   5.4 
OC use in 3 months before conception, % 13.6 13.9 17.0 16.5 13.9 14.4 16.1 18.1 
a Characteristics are standardized to maternal age using a SAS macro. 
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Table 2.2 PCE exposure and risk of TTP>12 months 
 
Exposure 
 
Cases / N 
Crude RR  
(95% CI) 
Adjusteda RR  
(95% CI) 
Adjustedb RR  
(95% CI) 
     
Cumulative PCE exposure (grams) 
   None 272 / 2202 Reference Reference Reference 
   Any 174 / 1624 0.97 (0.81, 1.16) 0.81 (0.67, 0.98) 0.85 (0.70, 1.03) 
     
   None 272 / 2202 Reference Reference Reference 
   >0-<10 50 / 546 0.84 (0.64, 1.09) 0.57 (0.32, 0.99) 0.76 (0.58, 1.00) 
   10-<100 71 / 663 1.02 (0.80, 1.29) 0.84 (0.63, 1.12) 0.91 (0.70, 1.17) 
   ≥100 53 / 415 1.08 (0.80, 1.46) 0.92 (0.71, 1.18) 0.90 (0.66, 1.24) 
     
Average monthly PCE exposure (grams) 
   None 306 / 2518 Reference Reference Reference 
   Any 140 / 1308 0.97 (0.81, 1.16) 0.87 (0.73, 1.05) 0.89 (0.73, 1.07) 
     
   None 306 / 2518 Reference Reference Reference 
   >0-<1 63 / 798 0.73 (0.57, 0.93) 0.64 (0.50, 0.82) 0.66 (0.51, 0.85) 
   1-<2.5 31 / 215 1.15 (0.84, 1.59) 1.05 (0.75, 1.45) 1.03 (0.74, 1.45) 
   ≥2.5 46 / 295 1.50 (1.16, 1.95) 1.40 (1.08, 1.81) 1.36 (1.06, 1.76) 
     
a Adjusted for maternal age.  
b Adjusted for maternal age, paternal age, year of pregnancy, maternal education, 
paternal occupation, first trimester cigarette smoking, first trimester alcohol intake, and 
pregnancy number. 
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Table 2.3 PCE exposure and risk of TTP>6 months 
 
Exposure 
 
Cases / N 
Crude RR  
(95% CI) 
Adjusteda RR  
(95% CI) 
Adjustedb RR  
(95% CI) 
     
Cumulative PCE exposure (grams) 
   None 435 / 2202 Reference Reference Reference 
   Any 288 / 1624 0.97 (0.84, 1.11) 0.83 (0.72, 0.96) 0.87 (0.75, 1.01) 
     
   None 435 / 2202 Reference Reference Reference 
   >0-<10 90 / 546 0.89 (0.73, 1.08) 0.79 (0.65, 0.96) 0.82 (0.67, 1.01) 
   10-<100 118 / 663 1.03 (0.86, 1.23) 0.89 (0.74, 1.07) 0.94 (0.77, 1.13) 
   ≥100 80 / 415 0.99 (0.78, 1.26) 0.81 (0.63, 1.03) 0.84 (0.65, 1.07) 
     
Average monthly PCE exposure (grams)  
   None 491 / 2518 Reference Reference Reference 
   Any 232 / 1308 0.97 (0.85, 1.11) 0.89 (0.78, 1.02) 0.91 (0.79, 1.05) 
     
   None 491 / 2518 Reference Reference Reference 
   >0-<1 121 / 798 0.85 (0.72, 1.00) 0.76 (0.62, 0.91) 0.79 (0.66, 0.95) 
   1-<2.5 47 / 215 1.11 (0.88, 1.40) 1.03 (0.81, 1.30) 1.02 (0.80, 1.29) 
   ≥2.5 64 / 295 1.19 (0.96, 1.48) 1.12 (0.91, 1.39) 1.10 (0.89, 1.36) 
     
a Adjusted for maternal age.  
b Adjusted for maternal age, paternal age, year of pregnancy, maternal education, 
paternal occupation, first trimester cigarette smoking, first trimester alcohol intake, and 
pregnancy number. 
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Table 2.4 PCE exposure and time-to-pregnancy 
 TTP 3-6 months  
vs. <3 months 
 TTP 7-12 months  
vs. <3 months 
 TTP >12 months  
vs. <3 months 
 
Exposure Events/N 
Adjusteda RR 
(95% CI) Events/N 
Adjusteda RR 
(95% CI) Events/N 
Adjusteda RR 
(95% CI) 
       
Cumulative PCE exposure (grams)   
   None 335 / 2202 Reference 163 / 2202 Reference 272 / 2202 Reference 
   Any 270 / 1624 0.96 (0.83, 1.12) 114 / 1624 0.89 (0.71, 1.13) 174 / 1624 0.85 (0.71, 1.01) 
       
   None 335 / 2202 Reference 163 / 2202 Reference 272 / 2202 Reference 
   >0-<10 90 / 546 0.96 (0.78, 1.17) 40 / 546 0.90 (0.65, 1.23) 50 / 546 0.80 (0.63, 1.00) 
   10-<100 110 / 663 0.96 (0.79, 1.16) 47 / 663 0.96 (0.72, 1.28) 71 / 663 0.89 (0.70, 1.11) 
   ≥100 70 / 415 0.99 (0.77, 1.27) 27 / 415 0.78 (0.52, 1.16) 53 / 415 0.86 (0.64, 1.15) 
       
Average monthly PCE exposure (grams)    
   None 392 / 2518 Reference 185 / 2518 Reference 306 / 2518 Reference 
   Any 213 / 1308 0.95 (0.83, 1.10) 92 / 1308 0.91 (0.74, 1.13) 140 / 1308 0.87 (0.74, 1.02) 
       
   None 392 / 2518 Reference 185 / 2518 Reference 306 / 2518 Reference 
   >0-<1 132 / 798 0.96 (0.81, 1.13) 58 / 798 0.94 (0.73, 1.21) 63 / 798 0.67 (0.54, 0.83) 
   1-<2.5 33 / 215 0.94 (0.73, 1.21) 16 / 215 1.03 (0.70, 1.53) 31 / 215 0.98 (0.73, 1.31) 
   ≥2.5 48 / 295 0.96 (0.76, 1.22) 18 / 295 0.78 (0.50, 1.21) 46 / 295 1.26 (1.01, 1.58) 
       
a Adjusted for maternal age, paternal age, year of pregnancy, maternal education, paternal occupation, first trimester cigarette 
smoking, first trimester alcohol intake, and pregnancy number. 
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Table 2.5 PCE exposure and risk of TTP>12 months, stratified by maternal age 
 Maternal age <30 years  Maternal age ≥30 years 
Exposure Events / N Adjusted RR  (95% CI)  Events / N 
Adjusted RR  
(95% CI) 
     
Cumulative PCE exposure (grams) 
   None 198 / 1740 Reference  74 / 462 Reference 
   Any 95 / 1020 0.80 (0.62, 1.02)  79 / 604 0.95 (0.69, 1.32) 
      
   None 198 / 1740 Reference  74 / 462 Reference 
   >0-<10 28 / 361 0.66 (0.46, 0.96)  22 / 185 0.93 (0.60, 1.45) 
   10-<100 42 / 429 0.87 (0.63, 1.19)  29 / 234 0.98 (0.64, 1.50) 
   ≥100 25 / 230 0.90 (0.59, 1.38)  28 / 185 0.94 (0.58, 1.52) 
      
Average monthly PCE exposure (grams) 
   None 215 / 1903 Reference  91 / 615 Reference 
   Any 78 / 857 0.80 (0.63, 1.03)  62 / 451 1.00 (0.74, 1.35) 
      
   None 215 / 1903 Reference  91 / 615 Reference 
   >0-<1 32 / 491 0.61 (0.43, 0.87)  31 / 307 0.76 (0.53, 1.11) 
   1-<2.5 20 / 158 0.93 (0.58, 1.49)  11 / 57 1.32 (0.80, 2.20) 
   ≥2.5 26 / 208 1.16 (0.81, 1.66)  20 / 87 1.60 (1.09, 2.35) 
      
a Adjusted for maternal age and pregnancy number. 
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Table 2.6 PCE exposure and risk of TTP>12 months, stratified by parity 
 Nulliparous  Parous 
Exposure Events / N Adjusted RR  (95% CI)  Events / N 
Adjusted RR  
(95% CI) 
     
Cumulative PCE exposure (grams) 
   None 134 / 1078 Reference  138 / 1124 Reference 
   Any 66 / 448 0.98 (0.74, 1.31)  108 / 1176 0.77 (0.61, 0.98) 
      
   None 134 / 1078 Reference  138 / 1124 Reference 
   >0-<10 18 / 173 0.70 (0.43, 1.14)  32 / 373 0.81 (0.57, 1.14) 
   10-<100 32 / 187 1.21 (0.84, 1.73)  39 / 476 0.72 (0.51, 1.02) 
   ≥100 16 / 88 1.09 (0.62, 1.92)  37 / 327 0.80 (0.55, 1.17) 
      
Average monthly PCE exposure (grams) 
   None 144 / 1122 Reference  162 / 1396 Reference 
   Any 56 / 404 0.88 (0.66, 1.19)  84 / 904 0.82 (0.65, 1.02) 
      
   None 144 / 1122 Reference  162 / 1396 Reference 
   >0-<1 25 / 225 0.71 (0.46, 1.09)  38 / 573 0.61 (0.45, 0.81) 
   1-<2.5 11 / 73 0.82 (0.40, 1.66)  20 / 142 1.08 (0.71, 1.65) 
   ≥2.5 20 / 106 1.32 (0.87, 2.00)  26 / 189 1.31 (0.93, 1.84) 
      
a Adjusted for maternal age and pregnancy number.  
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Figure 2.1 Association between cumulative PCE exposure and risk of TTP>12 
months, fit using restricted cubic splines 
The reference level for the RR is 0 grams (unexposed).  The curve is adjusted for 
maternal age, paternal age, year of pregnancy, maternal education, paternal occupation, 
first trimester cigarette smoking, first trimester alcohol intake, and pregnancy number.  
The solid line represents the RR, and the shaded area represents the 95% confidence 
band.  The spline is trimmed at the 95th percentile (due to the highly right-skewed 
distribution) and has three knot points each at the 50th, 75th, and 90th percentiles. 
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Figure 2.2 Association between average monthly PCE exposure and risk of TTP>12 
months, fit using restricted cubic splines 
The reference level for the RR is 0 grams (unexposed).  The curve is adjusted for 
maternal age, paternal age, year of pregnancy, maternal education, paternal occupation, 
first trimester cigarette smoking, first trimester alcohol intake, and pregnancy number.  
The solid line represents the RR, and the shaded area represents the 95% confidence 
band.  The spline is trimmed at the 95th percentile (due to the highly right-skewed 
distribution) and has three knot points each at the 50th, 75th, and 90th percentiles. 
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3 PERCEIVED STRESS AND FECUNDABILITY: A PRECONCEPTION 
COHORT STUDY OF NORTH AMERICAN COUPLES 
3.1 INTRODUCTION 
 In North America, 20-25% of women and 18-21% of men of reproductive age 
report experiencing intense daily psychological stress.1,2  Stress adversely affects quality 
of life and is associated with cardiovascular disease and mental illness, accelerated 
disease progression, poorer health habits, and premature mortality.3-7  The physiology of 
the human stress response is well-established.  A stimulus that is perceived as stressful 
results in signaling to the hypothalamus, which activates the sympathetic 
adrenomedullary (SAM) axis and causes increases in blood norepinephrine and salivary 
alpha-amylase.  If the stress becomes chronic, the SAM axis remains hyperactive, while 
the hypothalamic-pituitary-adrenal (HPA) axis is also activated, resulting in increased 
blood and salivary cortisol.  Suppression of the hypothalamic-pituitary-gonadal axis by 
HPA axis activation represents a physiologic link between the stress response and the 
female reproductive system.8 
Reports among infertile couples of spontaneous conception following adoption of 
a child9,10 and improved in vitro fertilization (IVF) outcomes after randomization to 
psychiatric interventions11-13 indicate that stress affects fertility.  Among females, stress 
may influence fertility by delaying or inhibiting the luteinizing hormone surge of the 
menstrual cycle,14 affecting gamete transport,15 or creating an unfavorable environment 
for implantation.16  It may also work indirectly through decreased intercourse frequency, 
decreased sleep duration, and increased uptake of unhealthy coping behaviors.17-20  
		
44 
Epidemiologic studies of female stress and fertility report conflicting results.  
Perceived stress has been associated with lower estradiol and luteinizing hormone 
concentrations, higher follicle-stimulating hormone concentrations, and increased risk of 
anovulation among healthy reproductive-aged women.21  The Oxford Conception Study 
in the United Kingdom22 and the LIFE study in the United States (U.S.)23 found inverse 
associations between salivary levels of alpha-amylase, but not cortisol, and fecundability.  
Studies of questionnaire-based measures of stress and fecundability have reported an 
inverse association with luteal phase psychologic distress among women with long 
menstrual cycles only,24 an inverse association with follicular phase stress but a positive 
association with luteal phase stress,25 or no substantial association.26  Much of the 
inconsistency in the literature may stem from differing methods used to measure stress 
and the varied timing of stress measurements. 
Among males, stress may affect fertility through decreased testosterone levels and 
altered spermatogenesis.27  Psychological stress can also lead to erectile dysfunction and 
ejaculatory problems.28,29  Studies of male medical students during examinations30,31 and 
men experiencing war-time conditions,32-34 work-related stress35 and recent 
bereavement36 provide evidence that psychological stress adversely affects sperm 
concentration and semen quality.  The only epidemiologic study to examine the 
association between male stress and fertility found that psychological stress,37 but not job 
strain (high job demands and low job control),38 was associated with reduced 
fecundability. 
 In the present study, we examine the association between perceived stress and 
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fecundability in a North American cohort of couples planning a pregnancy.  In addition to 
examining the effects of female and male stress separately, we also assess effect 
modification by partner stress. 
3.2 METHODS 
3.2.1 Study population 
Pregnancy Study Online (PRESTO) is an ongoing web-based preconception 
cohort study of pregnancy planners from North America.39  Eligible women are 21-45 
years old, residents of the U.S. or Canada, not using fertility treatments, and attempting to 
conceive.  Women complete an online screening questionnaire to determine their 
eligibility.  Study participation involves completion of an online baseline questionnaire 
on demographic, behavioral, medical, and reproductive factors and online follow-up 
questionnaires every two months to assess pregnancy status and update exposure 
information.  Women are randomized with 50% probability to receive a premium 
subscription to Fertility Friend, a menstrual cycle and fertility charting application.  After 
completing the baseline questionnaire, women are given the opportunity to invite their 
male partners to participate.  Males age ≥21 years are eligible for participation, which 
involves completion of a short baseline questionnaire, but no follow-up questionnaires.  
Ten days after completion of the baseline questionnaire, female and male participants are 
invited to complete a one-time food frequency questionnaire (FFQ).40 
From June 2013 through May 2017, 4,813 women completed the baseline 
questionnaire.  For the present analysis, we excluded women with a last menstrual period 
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(LMP) date at least six months prior to baseline (n=121) or implausible LMP dates (n=9), 
and who reported a history of infertility (n=143).  We additionally excluded women who 
had been attempting conception for more than 6 cycles at study entry (n=830) to reduce 
the possibility of reverse causation (i.e., taking longer to conceive causing higher levels 
of stress at baseline).  For women who did not complete any follow-up questionnaires 
(n=413), we assigned one menstrual cycle of follow-up and imputed their pregnancy 
status over that one cycle using multiple imputation (see below).  The final sample for 
analyses of female stress and fecundability included 3,685 women; the final sample for 
analyses of male stress, couple stress, and fecundability was restricted to couples where 
both partners participated (n=1,018). 
 This study was approved by the Institutional Review Board at Boston University 
Medical Center and all participants provided informed consent. 
3.2.2 Assessment of exposure 
We measured perceived stress using the 10-item version of the perceived stress 
scale (PSS), a scale designed to assess how unpredictable, uncontrollable, and 
overwhelming individuals find their life circumstances.41  Given that stress-associated 
pathology results from the cognitively-mediated response to a stressful event, rather than 
the event itself, the PSS is considered a better measure of stress than objective measures 
of stressful events.41  The PSS was designed to assess the effect of stress on illness 
among community-based samples with at least an 8th grade education.  Reliability studies 
demonstrate that the PSS effectively captures stress over the last four to eight weeks, but 
not long-term stress.18,41,42 
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We included the PSS on the female and male baseline questionnaires, as well as 
on all female follow-up questionnaires.  The items referred to the past month, with five 
response choices ranging from 0 (never) to 4 (very often).  We summed the responses to 
each of the ten items to compute the perceived stress score, after reverse scoring four 
items that were phrased positively (range of possible scores=0-40, with higher scores 
indicating higher perceived stress). 
3.2.3 Assessment of outcome 
On each follow-up questionnaire, we asked women if they were currently 
pregnant and, if not, if they had experienced any pregnancy losses (miscarriages, induced 
abortions, ectopic pregnancies) since their last questionnaire.  We also asked women at 
each follow-up if they were still trying to conceive and if they had initiated fertility 
treatment.  We attempted to ascertain pregnancy information from women who were lost 
to follow-up by contacting participants via telephone, linking participant data with birth 
registries from selected states, using data from Fertility Friend, searching for baby 
registries on the web, and searching for baby announcements on social media. 
On the baseline questionnaire, we asked women if their menstrual cycles were 
regular, meaning they could usually predict within a few days when their next period 
would start.  We asked women with regular cycles about their usual cycle length.  For 
women with irregular cycles, we estimated usual cycle length using information on their 
LMP dates at baseline and over follow-up.  At baseline, we asked women how many 
menstrual periods they had had since they began trying to conceive.  We calculated study 
time, rounded to the nearest whole cycle as follows: (menstrual cycles of attempt time at 
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baseline) + [(LMP date from most recent follow-up questionnaire - date of baseline 
questionnaire)/usual cycle length] + 1. 
3.2.4 Assessment of covariates 
We collected covariate information on the female and male baseline 
questionnaires, including age, race/ethnicity, geographic region of residence, education, 
household income, marital status, height, weight, sleep duration, employment status, 
hours/week of work, smoking history, passive smoke exposure, alcohol and caffeine 
consumption, intake of sugar-sweetened beverages, physical activity, intercourse 
frequency, use of methods to improve chances of conception, multivitamin and folic acid 
use, depressive symptoms (major depression inventory (MDI) score43), physician 
diagnosis of medical conditions (including depression, anxiety, uterine leiomyomata, 
endometriosis, polycystic ovarian syndrome, pelvic inflammatory disease, sexually 
transmitted infections), pap smear within the past three years, history of abnormal pap 
smears, pregnancy history, and occupational exposures.  Data on smoking, alcohol, 
caffeine, physical activity, intercourse frequency, multivitamin intake, and menstrual 
cycle characteristics (menstrual cycle regularity and length) were updated over time on 
the female follow-up questionnaires.  From the FFQ, we calculated the Healthy Eating 
Index (HEI) score.44,45 
3.2.5 Statistical analysis 
We conducted a factor analysis using orthogonal rotation to identify domains 
within the PSS.  Our analysis revealed two factor loadings, confirming the results from 
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studies assessing the psychometric properties of the PSS.18,46-50  The first factor included 
the six negatively worded items on stress (items 1, 2, 3, 6, 9, and 10) and had factor 
loadings from 0.61 to 0.77.  The second factor included the four positively worded items 
on coping skills (items 4, 5, 7, and 8) and had factor loadings from 0.62 to 0.77.  Use of 
the promax rotation to allow for correlation between variables generated similar results.  
The Cronbach’s alpha for the six stress items and the four coping items were 0.84 and 
0.75, respectively, indicating high internal consistency. 
We used multiple imputation to impute missing exposure, covariate, and outcome 
data (conception, yes vs. no).51-53  We generated five imputation data sets using a Markov 
chain Monte Carlo method.54  Eleven percent of outcomes were imputed.  Fewer than 
0.1% of values were missing for female PSS score.  The male PSS was added to the 
baseline questionnaire in January 2015; therefore, 51.5% of values were missing.  
Covariate missingness ranged from 0% (age) to 3% (income).   
We used the Anderson-Gill data structure,55,56 with one observation per menstrual 
cycle at risk, to update covariates over time and to account for left truncation.57,58  
Women contributed observed menstrual cycles to the analysis from study entry until 
pregnancy, fertility treatment, cessation of pregnancy attempt, loss to follow-up, or 12 
cycles, whichever came first.  We used a proportional probabilities regression model to 
examine the association between PSS score and fecundability.  This log-binomial model 
estimates fecundability ratios (FR), the per-cycle probability of conception comparing 
exposed with unexposed individuals, and 95% confidence intervals (CI).  The model 
includes indicator variables for cycle number at risk in order to account for the decline in 
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baseline fecundability over time. 
For females, we examined PSS score at baseline, as a time-varying variable, and 
as a cumulative average variable (for each cycle, the average PSS score from baseline 
through that cycle).  We examined PSS score in males at baseline only.  There are no 
clinical cut points for the PSS scale; therefore, PSS scores were categorized based on the 
distribution in the analytic cohort: <10 (reference), 10-14, 15-19, 20-24, and ≥25.  We 
also assessed the shape of the curve relating PSS score and fecundability using restricted 
cubic splines.59,60  Next, we ran models for each individual item on the PSS, examining 
fecundability for each response option compared with the reference group (“never” for 
the negatively worded items and “very often” for the positively worded items).  We 
conducted a couples-based analysis comparing fecundability within joint categories of 
female and male PSS scores (<10, 10-19, ≥20). 
We adjusted all models for putative confounders, identified from the literature and 
a causal directed acyclic graph (Figure 3.1; assumed to be identical for females and 
males, with the “irregular cycles” variable removed for males), including age (<25, 25-
29, 30-34, ≥35 years), body mass index (BMI; <25, 25-29, 30-34, ≥35 kg/m2), 
race/ethnicity (non-Hispanic white vs. not), education (≤high school education, some 
college, college degree, graduate school), annual household income (<$50,000, $50,000-
$99,999, $100,000-$149,99, ≥$150,000), and employment (<20, 20-39, 40-49, ≥50 
hours/week, unemployed).  We ran separate models additionally adjusted for variables 
that may act as either confounders or mediators, depending on the temporality of the 
relationships (Figure 3.1), including smoking history (never, former, current occasional, 
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current regular), alcohol use (0, 1-6, 7-13, ≥14 drinks/week), caffeine intake (<100, 100-
199, 200-299, ≥300 mg/day), sleep duration (<7, 7-8, ≥9 hours/night), MDI score (<20, 
20-24, 25-29, ≥30), intercourse frequency (time-varying; <1, 1, 2-3, ≥4 times/week), and 
irregular cycles (yes, no).   
To assess the possibility of reverse causation, we stratified models by cycles of 
attempt at study entry (<3 vs. 3-6).  We also performed a sensitivity analysis examining 
the association between PSS score and fecundability in the first observed cycle only.  We 
stratified models by female age (<35 vs. ≥35 years) to determine whether the relation 
between stress and fecundability was stronger in older women.  Because studies have 
indicated that stress levels and the relation between stress and fertility may vary across 
the menstrual cycle,25 we stratified baseline only PSS models by menstrual cycle phase at 
baseline (luteal phase, defined as expecting the next period within 14 days of baseline vs. 
follicular phase, defined as expecting the next period in at least 14 days).  Lastly, we 
stratified models by cycle length (≤35 vs. >35 days), as one study observed an association 
between stress and fecundability among women with long menstrual cycles only.22 
In agreement with other studies,61 loss to follow-up in PRESTO differed by 
baseline stress: among women with PSS scores ≥25 and <25, the proportion lost to 
follow-up was 32.4% and 22.3%, respectively.  We corrected for differential loss to 
follow-up using inverse probability of continuation weights.62-65  First, we developed 
pooled logistic regression models for the probability of continuing in the study at each 
observed menstrual cycle, conditional on remaining uncensored in the previous cycle.  
We modeled a set of variables, some of which were time-varying, hypothesized to predict 
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loss to follow-up, including: smoking history, passive smoke exposure, alcohol intake, 
BMI, daily multivitamin or folic acid intake, current marijuana use, age, HEI score, 
race/ethnicity, marital status, geographic region of residence, annual household income, 
education, employment status, hours/week of work, exposure to occupational hazards, 
average sleep duration, parity, doing something to improve chances of conception (e.g., 
charting menstrual cycles, using ovulation prediction kits, measuring basal body 
temperature), MDI score, pap smear in past three years, history of abnormal pap smear, 
male partner participation status, and completion of the FFQ.  We fitted a separate pooled 
logistic regression model in which only baseline variables were included as independent 
variables.  From these models, we calculated the predicted probability of continuation for 
each observation.  We used these probabilities to compute stabilized weights that are 
inversely proportional to the probability of remaining in the study at each questionnaire 
cycle.  For each cycle, let Cik indicate whether person i is lost to follow-up at cycle k.  Let 
X be perceived stress, L be a set of variables (some of which are time-varying) that 
predict loss to follow-up and V be a subset of L including baseline variables only.  The 
stabilized weight for an individual’s contribution to cycle j is: 
stwtij= Π (Pr [Cik=0 | Ci(k-1)=0,Xi,Vi]) / (Pr [Cik=0 | Ci(k=1)=0,Xi,Li]) 
Observations with a low probability of continuation were assigned larger weights 
in order to compensate for the underrepresentation of those types of individuals in the 
data.  We applied stabilized weights to the proportional probabilities regression models 
and report weighted FRs and 95% CIs.   
High levels of stress may cause sleep disturbances, depressive symptoms, uptake 
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of unhealthy stress-reduction behaviors (e.g., cigarette smoking, alcohol consumption, 
and caffeine intake), lower intercourse frequency, and abnormal menstrual function.17-
20,66  We examined whether any observed association between perceived stress and 
fecundability was partially or completely mediated through these variables using a causal 
mediation analysis.67-70  Information on sleep, depressive symptoms, smoking, alcohol, 
caffeine, intercourse frequency, and menstrual cycle regularity were measured 
concurrently with baseline PSS score; therefore, they may act as confounders or 
mediators (see Figure 3.1).  We performed the mediation analysis assuming that these 
variables were caused by stress, not causes of stress.  We estimated the direct effects of 
female baseline PSS score (≥25 vs. <25) on fecundability (natural direct effect, NDE) and 
effects that operate through the mediating variables (natural indirect effect, NIE), one at a 
time, adjusting for age, race/ethnicity, education, income, BMI, and employment 
status.71,72  We calculated the proportion mediated as [FRNDE*(FRNIE - 1)] / 
(FRNDE*FRNIE - 1).  We conducted this analysis on the first imputation data set only. 
3.3 RESULTS 
Overall, 3,685 women contributed 14,514 menstrual cycles at risk to the analysis; 
1,018 men had female partners who contributed 4,173 menstrual cycles at risk.  Over 
follow-up, we identified 2,193 (59.5%) incident pregnancies: 1,794 pregnancies self-
reported on a follow-up questionnaire, 270 pregnancies identified using other methods 
(e.g., birth registry linkage, social media baby announcements), and 129 pregnancies 
(imputed) to women with no follow-up data.  Of the remaining 1,492 women, 256 
initiated fertility treatment, 32 stopped trying to conceive, 522 were censored at 12 
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cycles, 448 were lost to follow-up (imputed as non-pregnancies), and 234 were still 
actively participating in the study.   
At baseline, women had higher levels of stress than men.  Mean PSS scores were 
15.6 (standard deviation (SD)=5.7, range=0-36) and 14.4 (SD=5.9, range=0-36), 
respectively; 6.9% of women and 5.3% of men had PSS scores ≥25.  PSS scores tended 
to increase throughout follow-up among women: those observed in cycle 1 (n=666) had 
mean cycle 1 PSS scores of 15.0 (SD=5.6), whereas those observed in cycles 6 (n=1,518) 
and 12 (n=587) had mean PSS scores of 15.6 (SD=5.9) and 16.0 (SD=6.1) at cycles 6 and 
12, respectively. 
Higher female PSS scores were associated with longer pregnancy attempt times at 
study entry, higher BMI, current smoking, higher alcohol use, caffeine intake, 
hours/week of work, MDI score, history of physician-diagnosed depression or anxiety, 
gravidity, irregular cycles, and short cycles, and inversely associated with age, white non-
Hispanic race/ethnicity, education, income, physical activity, sleep duration, regular 
multivitamin intake, and intercourse frequency (Table 3.1).  Patterns were similar for 
males, although male PSS scores were not substantially associated with age, alcohol use, 
or physical activity.  Although PSS scores increased with increasing partner PSS score, 
female and male PSS scores were not strongly correlated (Pearson correlation 
coefficient=0.16).  
After adjusting for confounders, we observed an inverse association between 
perceived stress and fecundability (Table 3.2).  Compared with baseline PSS scores <10, 
women with baseline PSS scores of 10-14, 15-19, 20-24, and ≥25 had FRs of 0.95 (95% 
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CI: 0.84, 1.07), 0.94 (95% CI: 0.83, 1.06), 0.92 (95% CI: 0.80, 1.07), and 0.81 (95% CI: 
0.66, 0.99).  When we additionally adjusted for variables that may act as confounders or 
mediators, depending on the temporality of the associations, results were slightly 
dampened (FR comparing baseline PSS score ≥25 with <10=0.88, 95% CI: 0.71, 1.09).  
Results for time-varying and cumulative average PSS score were similar to the baseline 
only results.  When we restricted the sample to females whose male partners participated 
in the study, results were stronger (FR comparing baseline PSS score ≥25 with <10=0.55, 
95% CI: 0.37, 0.83), but additional adjustment for male PSS score did not substantially 
change the results.  The restricted cubic spline analysis generally supported the 
categorical results.  Fecundability declined slightly with increasing female baseline PSS 
score from 0 to 15, then declined more sharply in a linear relationship at higher PSS 
scores (Figure 3.2). 
The association between female baseline PSS score and fecundability was slightly 
stronger among women who had been attempting conception for 3-6 cycles at study entry 
(FR comparing baseline PSS score ≥25 with <10=0.75, 95% CI: 0.48, 1.17) as compared 
with those who had been attempting conception for <3 cycles (FR comparing baseline 
PSS score ≥25 with <10=0.83, 95% CI: 0.66, 1.04; Table 3.3).  When we restricted the 
analysis to the first observed cycle, results were stronger than the primary analysis: FRs 
for female baseline PSS scores 10-14, 15-19, 20-24, and ≥25 compared with <10 were 
0.86 (95% CI: 0.71, 1.05), 0.94 (95% CI: 0.79, 1.13), 0.85 (95% CI: 0.67, 1.07), and 0.63 
(95% CI: 0.44, 0.89), respectively. 
The association was stronger among younger women (age <35 years, FR 
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comparing baseline PSS score ≥25 with <10=0.79, 95% CI: 0.64, 0.97; age ≥35 years, the 
corresponding FR=0.94, 95% CI: 0.72, 1.24; Table 3.4).  Results did not differ 
substantially between nulliparous (n=2,716) and parous (n=969) women, women with 
cycle lengths ≤35 (n=3,417) and >35 days (n=268), or women who completed baseline 
during their luteal (n=1,747) and follicular (n=1,938) phases (data not shown). 
Male PSS score was not substantially associated with fecundability (Table 3.2); 
adjustment for female PSS score made little difference in FRs (data not shown).  Results 
were similar when restricting to men with complete (i.e., unimputed) data on PSS score 
(n=494).  In the restricted cubic spline analysis, we also observed little relation between 
male PSS score and fecundability (Figure 3.2).  Male PSS and fecundability results were 
similar across strata of attempt time at study entry and female age, and when restricted to 
the first observed cycle of follow-up.  We did observe a small inverse association 
between male PSS score and fecundability among men with a parous female partner (FR 
comparing PSS score ≥25 vs. <10=0.89, 95% CI: 0.47, 1.68), but not among men with a 
nulliparous female partner (corresponding FR=1.12, 95% CI: 0.69, 1.83). 
The assessment of individual items on the PSS scale in relation to fecundability 
revealed no clear pattern of association among either females or males (Table 3.5).  Item 
7 (“How often have you been able to control irritations in your life?”) showed the 
strongest association with reduced fecundability in females (FR comparing “never” with 
“very often”=0.60, 95% CI: 0.26, 1.40); item 6 (“How often have you found that you 
could not cope with all the things that you had to do?”) showed the strongest association 
with reduced fecundability in males (FR comparing “very often” with “never”=0.77, 95% 
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CI: 0.45, 1.31). 
When we examined the joint association of male and female PSS scores with 
fecundability, we observed lower fecundability in couples with discordant PSS scores 
between the female and male partners (Table 3.6).  For example, among couples where 
the male partner had a PSS score <10, FRs for female PSS scores of 10-19 and ≥20 were 
0.76 (95% CI: 0.49, 1.17) and 0.60 (95% CI: 0.30, 1.20), respectively, compared with 
female PSS scores <10.  Likewise, among couples where the female partner had a PSS 
score <10, FRs for male PSS scores of 10-19 and ≥20 were 0.95 (95% CI: 0.58, 1.56) and 
0.85 (95% CI: 0.43, 1.70), respectively, compared with male PSS scores <10.  On the 
other hand, couples where both partners had PSS scores ≥20 did not have reduced 
fecundability compared with couples where both partners had PSS scores <10, although 
results were imprecise (FR=1.16, 95% CI: 0.75, 1.79). 
A total of 847 women (23.0%) were lost to follow-up, which was defined as not 
completing the most recent follow-up questionnaire, regardless of whether pregnancies 
were ascertained via other methods.  Baseline stress was positively associated with loss to 
follow-up: among women with PSS scores ≥25, 32.4% were lost, whereas among women 
with score <25, only 22.3% were lost.  The strongest predictors of continuation were 
completion of the FFQ, high education level, and male partner participation.  The model 
predicting continuation in the study generally fit the data well, with a c-statistic of 0.82.  
Stabilized weights generated from the prediction model had a mean of 1.09 and ranged 
from 0.17 to 7.41.  When we applied these weights to the model examining the 
association between female baseline PSS and fecundability, results were similar to the 
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main analysis (FR comparing baseline PSS score ≥25 with <10=0.83, 95% CI: 0.68, 
1.02). 
In mediation analyses (Table 3.7), natural indirect effects were small (range: 
FR=0.98-1.02), whereas natural direct effects were similar to the overall association (FR 
comparing baseline PSS score ≥25 vs. <25=0.87, 95% CI: 0.73, 1.03).  The proportion of 
the association between PSS score and fecundability that was mediated by other variables 
did not exceed 15% for any given mediator, and was highest for sleep duration (13.3%), 
MDI score (5.8%), and menstrual cycle irregularity (4.6%). 
3.4 DISCUSSION 
In this preconception cohort study of North American pregnancy planners, we 
found that high female, but not male, perceived stress was associated with lower 
fecundability.  Results were similar when female stress was analyzed as a fixed baseline, 
time-varying, or cumulative average variable.  Findings were relatively consistent across 
strata of attempt time at study entry, but were stronger among younger women.  
We measured stress using the PSS, which is a validated scale that reflects 
perceived stress in a relatively short time frame (i.e., approximately four to eight 
weeks).18  Our results are not consistent with the one prior study that has examined the 
relation of PSS score and fecundability.  Among 339 female pregnancy planners in the 
Oxford Conception Study, PSS score measured on day six of each menstrual cycle of 
follow-up was not substantially associated with fecundability (FRs for PSS score 10-14, 
15-19, and ≥20 vs. <10 were 0.81 (95% CI: 0.52, 1.25), 0.98 (95% CI: 0.61, 1.56), and 
0.94 (95% CI: 0.59, 1.50), respectively).26  Our strongest findings were among women 
		
59 
with PSS scores ≥25; it is possible that the difference in categories between the two 
studies explains the discrepant findings. 
Our results are partially consistent with a study of 430 Danish pregnancy planners 
where there was an association between short-term psychological distress (measured by 
the General Health Questionnaire) on day 21 of each menstrual cycle and reduced 
fecundability.24  However, unlike the Danish study, we did not observe effect 
modification by cycle length. 
Other studies of stress and fertility have measured stress at a more granular level, 
with either daily stress diaries or measurement of salivary biomarkers of stress.  In the 
Mount Sinai Study of Women Office Workers, women reported stress levels from 1-4 on 
a daily basis; a 1-unit increase in self-reported stress during the ovulatory and pre-
ovulatory window was associated with 46% and 27% reductions in fecundability, 
respectively.25  Among 274 female pregnancy planners from the Oxford Conception 
Study, a 1-unit increase in the natural logarithm of salivary alpha-amylase measured on 
the sixth day of each menstrual cycle was associated with a 10% reduction in first cycle 
fecundability (95% CI: 29%, -13%).22  Likewise, pregnancy planners from Michigan and 
Texas (n=373) in the highest tertile of salivary alpha-amylase (measured on first day of 
the first observed menstrual cycle) had a fecundability odds ratio of 0.71 (95% CI: 0.51, 
1.00) compared with women in the lowest tertile.23  We were not able to capture more 
acute stress during specific windows of susceptibility, for example, during ovulation or 
implantation.  We attempted to account for temporal variability in baseline PSS 
assessment by stratifying our models by menstrual cycle phase at baseline (follicular vs. 
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luteal); we found that results were similar in the two phases.  However, we defined 
menstrual cycle phase based on the self-reported number of days until the next period 
was expected, which may be prone to misclassification.73 
We ascertained PSS score every eight weeks, but asked the questions in reference 
to the previous four weeks.  When we restricted to the first observed cycle of pregnancy 
attempt, our results were stronger, indicating that bias towards the null due to non-
differential exposure misclassification may be present. 
Our results using baseline only, time-varying, and cumulative average levels of 
PSS scores were not substantially different from each other.  However, this could be 
explained by strong correlation between the three measures: correlation coefficients 
ranged from 0.88 to 0.97, and over 75% of women remained in the same PSS score 
category throughout follow-up.  Neither our study nor others have measured the 
association between chronic stress over a longer period of time (ranging from several 
years to throughout the life course) on fecundability.   
Ours is the first study to report that male partner stress may modify the 
association between female stress and fecundability, with partner stress discordance 
resulting in stronger associations.  Concordance of stress levels between partners may be 
a marker for relationship quality.  For example, in a study of infertile couples, equal 
levels of infertility-related stress and desire for parenthood were associated with 
improved marital adjustment, in particular among females.74  In the same study, 
discordance over relationship concerns was associated with depression in females, but not 
males.74  The “buffering model” of stress hypothesizes that positive quality relationships 
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can buffer the health effects of stress.75  High quality relationships have been associated 
with faster recovery from work-related stress76 and improved survival after congestive 
heart failure.77  If relationship quality modifies the association between stress and 
fecundability, in particular among women, and if partner stress discordance is an accurate 
marker of relationship quality, this could explain why we see an association between 
female stress and fecundability only among women whose partners report low levels of 
perceived stress.  Results from the Oxford Conception Study also support this hypothesis: 
high levels of social support measured by the Medical Outcomes Study Social Support 
Survey78 were associated with improved fecundability,26 although they did not examine 
the relationship between PSS and fecundability within levels of social support.  We did 
not measure relationship quality or social support formally in our study.   
Female participants with the highest PSS scores had shorter sleep duration, larger 
caffeine intake, and higher MDI scores, and were more likely to be current regular 
smokers, have intercourse less often, and have irregular menstrual cycles.  However, the 
results of our mediation analysis indicated that these factors mediated a maximum of 
~14% of the association between female PSS and fecundability.  This observation lends 
support to the hypothesis that if perceived stress exerts a causal effect on fertility, it is 
likely through mechanisms other than behaviors measured in our study. 
Because difficulty conceiving can lead to higher stress levels,79 this association is 
particularly susceptible to reverse causation.  To reduce the likelihood of reverse 
causation in our main analysis, we restricted our analytic sample to women who did not 
have a history of infertility and who had been attempting conception for a relatively short 
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amount of time at study entry (0-6 cycles).  We additionally stratified models by attempt 
time at study entry (<3 vs. 3-6 cycles) and found that results were slightly stronger 
among women who had been attempting pregnancy for 3-6 cycles at study entry.  This 
finding indicates that a small proportion of our main findings could result from reverse 
causation.  We did not collect information on the major sources of stress (e.g., trying to 
get pregnant, job strain, financial stability, health concerns), which would have allowed a 
more detailed assessment of bias due to reverse causation. 
We found that the inverse association between PSS score and fecundability was 
present only among women <35 years.  The absence of an association among older 
women may reflect that causes of subfertility in older women are stronger than the effect 
of stress.  Our findings may also be due to chance. 
We did not measure male perceived stress over time and were therefore unable to 
examine the relation between male time-varying or cumulative PSS score and 
fecundability.  Time-varying and cumulative average results in females, however, were 
similar to baseline results, providing evidence that this is not an important source of bias.  
Moreover, any bias that resulted would have attenuated our findings. 
Women who are racial/ethnic minorities, low income, and who have low 
education levels and high BMI are more likely to recognize their pregnancies later in 
gestation.80  These factors were positively associated with perceived stress in our study.  
If high levels of perceived stress delay pregnancy recognition, then outcome 
misclassification may have biased our results, because non-stressed women would 
identify more early pregnancy losses than stressed women.  We did not collect 
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information on the timing of pregnancy recognition in our study, and therefore cannot 
directly assess the relation between stress and pregnancy recognition.  In addition, 
women with high stress levels at baseline may overestimate the number of cycles they 
had been trying to conceive at study entry compared with women with lower stress 
levels.  This differential outcome misclassification would be expected to result in an 
overestimate of the association between PSS score and fecundability. 
Adjustment for a wide range of demographic, behavioral, lifestyle, medical, 
reproductive, and dietary variables in both partners did not substantially alter the 
association between PSS and fecundability, indicating little confounding by measured 
variables.  It is possible that unmeasured confounding explains our results, although we 
do not have hypotheses about specific unmeasured confounding variables.  
Female participants with high baseline PSS scores were more likely to be lost to 
follow-up than those with lower scores.  We were able to account for potential 
differential loss to follow-up using inverse probability of continuation weights.  
However, we observed little difference in our results after applying these weights.   
Internet-based studies have been criticized as prone to selection bias because the 
characteristics of those with internet access differ from those without access.  Similarly, 
some have questioned the validity of studies of pregnancy planners because pregnancy 
planners differ from those who do not plan their pregnancies.  However, recruitment 
method should not affect the internal validity of the study unless the relation between 
perceived stress and fecundability differs based on internet access or pregnancy planning, 
which seems unlikely.  Furthermore, we have demonstrated in an internet-based cohort of 
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Danish pregnancy planners that even when enrollment is strongly related to factors such 
as age or parity, the measures of association are not necessarily biased due to self-
selection.81  
There are several biologic mechanisms through which female stress could directly 
affect fecundability.  Stress is associated with higher levels of corticotropin-releasing 
hormone and glucocorticoids, which suppress the function of gonadotropin-releasing 
hormone and may delay or inhibit the luteinizing hormone surge of the menstrual cycle.14  
Glucocorticoids may suppress the uterine cytokine NFkB and local inflammation, which 
are essential for implantation.16,82  Stress may also reduce ovarian reserve, as salivary 
alpha-amylase has been related to lower levels of anti-Müllerian hormone.83  In addition, 
a study of couples undergoing IVF found an association between stress and lower 
probability of pregnancy, and the effect was partially mediated by a lower number of 
oocytes harvested during oocyte retrieval.84 
In summary, in this large prospective cohort study of North American pregnancy 
planners, high levels of perceived stress among females were associated with reduced 
fecundability, particularly among women whose partners had lower perceived stress 
levels.  We measured female stress at multiple time points throughout the pregnancy 
attempt and evaluated bias due to differential loss to follow-up.  Our data indicated little, 
if any, mediation of the relationship between stress and fecundability by measured 
behavioral and lifestyle factors. 
  
		 65 
3.5 TABLES AND FIGURES 
Table 3.1 Baseline characteristics of female and male pregnancy planners by 10-item perceived stress scale score  
 Female PSS Score (n=3,685)  Male PSS Score (n=1,018) 
Characteristica <10 10-14 15-19 20-24 ≥25 <10 10-14 15-19 20-24 ≥25 
Number of participants 502 1164 1154   612 253 213   325   287   139     54 
Age (years), mean 30.5 30.2 29.9 29.3 29.2 31.4 31.5 31.6 31.6 31.3 
Partner’s age (years), mean 32.2 31.7 31.8 31.7 31.5 30.0 29.9 29.7 29.9 29.3 
Cycles of attempt at study entry, mean 1.8 2.0 2.1 2.3 2.2 1.9 1.9 1.9 2.0 2.1 
Partner’s PSS score, mean 12.5 14.1 15.0 15.1 16.0 13.9 14.6 15.6 16.0 17.0 
Non-Hispanic white, % 88.4 86.2 84.5 84.3 81.7 89.2 86.7 88.9 82.7 82.6 
<College degree, % 17.1 18.9 20.0 22.4 27.5 23.1 21.8 27.9 35.0 40.6 
Married, % 97.6 96.0 94.6 94.2 92.8 97.3 98.5 96.1 95.2 92.8 
Annual household income <$50,000, % 9.2 16.0 17.1 19.3 27.0 12.4 12.8 18.8 19.1 26.8 
BMI (kg/m2), mean 25.5 26.0 27.0 27.5 27.4 27.0 27.1 28.0 28.5 29.1 
Physical activity (MET-hours/wk), mean 39.2 37.6 34.6 34.0 31.3 34.3 34.3 32.2 32.8 36.1 
Stress-reduction activities ≥1 hour/wk, % 40.5 35.9 34.3 36.5 29.4 16.6 16.2 13.1 12.5 11.8 
Current regular smoker, % 4.6 5.3 4.8 5.0 6.5 2.4 3.2 7.3 6.9 9.1 
Current alcohol intake (drinks/wk), mean 3.4 3.3 3.4 3.3 4.5 6.4 5.7 6.9 6.8 5.0 
Current caffeine intake (mg/day), mean 107.5 115.7 124.5 124.2 131.4 158.6 156.6 198.6 186.7 274.0 
Sleep duration <7 hours/night, % 16.0 20.0 20.1 28.6 37.3 24.3 25.8 39.0 36.6 61.5 
Unemployed, % 1.7 2.8 3.0 3.8 6.6 1.9 2.1 2.4 1.4 13.7 
Work ≥50 hours/week, %b 9.9 12.3 12.3 14.0 18.9 28.6 28.9 30.9 34.3 31.6 
Regular multivitamin intake, % 88.7 81.8 81.2 77.6 79.1 36.7 34.9 33.6 29.9 25.2 
MDI score, mean 4.3 6.6 9.6 14.6 22.3 4.4 6.8 10.3 13.8 21.3 
History of depression, % 15.4 14.6 21.3 33.8 41.6 2.4 7.9 12.5 17.6 28.7 
History of anxiety, % 11.7 12.0 19.9 33.5 37.5 2.1 4.6 8.2 17.0 23.8 
Gravid, % 45.9 41.9 42.0 50.3 50.8 35.6 39.0 44.5 43.4 53.1 
Parous, % 28.5 26.1 24.6 28.1 26.2 -- -- -- -- -- 
History of spontaneous abortion, % 16.8 19.9 20.0 24.0 26.2 -- -- -- -- -- 
Intercourse frequency <1 time/week, % 14.9 18.3 20.9 22.4 23.5 12.0 19.6 21.6 16.3 29.3 
		 66 
Intercourse frequency ≥4 times/week, % 16.3 14.0 16.6 13.2 16.8 16.7 14.0 12.7 21.4 14.8 
Doing something to improve chances of 
conception, % 73.2 74.7 75.6 76.5 73.7 76.5 74.7 75.3 78.7 73.9 
Hormonal last method of contraception, % 37.1 38.9 38.4 38.1 32.8 33.3 34.5 35.3 32.9 42.9 
Irregular cycles, % 10.3 13.2 13.9 17.2 21.5 --  -- -- -- 
Cycle length <25 days, % 2.4 3.4 2.8 3.9 4.3 --  -- -- -- 
Cycle length ≥32 days, % 19.8 21.1 21.0 23.3 24.9 --  -- -- -- 
a All characteristics except for age are standardized to the cohort age at baseline. b Among employed individuals. 
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Table 3.2 Female and male PSS score and fecundability 
Exposure Pregnancies N 
Cycles 
N 
Unadjusted 
FR (95% CI) 
Adjusteda 
FR (95% CI) 
     
Female baseline PSS score    
   <10 337 1987 Reference Reference 
   10-14 715 4608 0.93 (0.83, 1.05) 0.95 (0.84, 1.07) 
   15-19 676 4490 0.92 (0.81, 1.04) 0.94 (0.83, 1.06) 
   20-24 340 2426 0.88 (0.76, 1.02) 0.92 (0.80, 1.07) 
   ≥25 125 1003 0.76 (0.62, 0.93) 0.81 (0.66, 0.99) 
Female time-varying PSS score    
   <10 355 2166 Reference Reference 
   10-14 699 4446 0.95 (0.84, 1.07) 0.96 (0.85, 1.08) 
   15-19 674 4336 0.95 (0.84, 1.07) 0.96 (0.86, 1.09) 
   20-24 334 2506 0.86 (0.74, 0.99) 0.89 (0.77, 1.03) 
   ≥25 131 1060 0.77 (0.64, 0.94) 0.82 (0.68, 1.00) 
Female cumulative average PSS score    
   <10 351 2071 Reference Reference 
   10-14 709 4667 0.91 (0.81, 1.02) 0.92 (0.82, 1.04) 
   15-19 686 4421 0.93 (0.83, 1.05) 0.95 (0.85, 1.07) 
   20-24 335 2443 0.86 (0.74, 0.99) 0.90 (0.78, 1.04) 
   ≥25 112   912 0.72 (0.59, 0.89) 0.77 (0.62, 0.95) 
Male baseline PSS score     
   <10 143   857 Reference Reference 
   10-14 212 1310 1.00 (0.78, 1.27) 0.99 (0.78, 1.26) 
   15-19 188 1207 1.06 (0.83, 1.35) 1.04 (0.83, 1.32) 
   20-24   87   586 1.03 (0.74, 1.42) 1.06 (0.77, 1.46) 
   ≥25   32   213 1.01 (0.67, 1.53) 1.01 (0.65, 1.56) 
     
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work 
duration. 
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Table 3.3 Female and male PSS score and fecundability, stratified by attempt time at study entry 
 Cycles of attempt at study entry 
 <3  3-6 
Exposure Pregnancies N 
Cycles 
N 
Adjusteda 
FR (95% CI)  
Pregnancies 
N 
Cycles 
N 
Adjusteda 
FR (95% CI) 
Female baseline PSS score      
   <10 273 1481 Reference    64   506 Reference 
   10-14 517 3121 0.92 (0.80, 1.05)  198 1487 1.05 (0.79, 1.39) 
   15-19 473 2958 0.89 (0.78, 1.02)  203 1532 1.07 (0.82, 1.41) 
   20-24 219 1528 0.86 (0.73, 1.01)  121   898 1.08 (0.79, 1.48) 
   ≥25   93   656 0.83 (0.66, 1.04)    32   347 0.75 (0.48, 1.17) 
Female time-varying PSS score      
   <10 282 1568 Reference    73   598 Reference 
   10-14 513 3027 0.94 (0.82, 1.07)  186 1419 1.00 (0.76, 1.31) 
   15-19 469 2888 0.91 (0.79, 1.04)  205 1448 1.08 (0.84, 1.40) 
   20-24 215 1569 0.83 (0.71, 0.98)  119   937 1.02 (0.75, 1.37) 
   ≥25   96   692 0.83 (0.66, 1.03)    35   368 0.78 (0.51, 1.17) 
Female cumulative average PSS score      
   <10 283 1528 Reference    68   543 Reference 
   10-14 515 3166 0.90 (0.79, 1.02)  194 1501 0.99 (0.75, 1.31) 
   15-19 477 2924 0.90 (0.79, 1.02)  209 1497 1.08 (0.83, 1.41) 
   20-24 216 1531 0.84 (0.71, 0.99)  119   912 1.03 (0.76, 1.40) 
   ≥25   84   595 0.79 (0.63, 1.00)    28   317 0.68 (0.43, 1.08) 
Male baseline PSS score      
   <10   99   551 Reference  44 306 Reference 
   10-14 164   958 0.98 (0.75, 1.27)  48 352 1.09 (0.67, 1.77) 
   15-19 146   868 1.06 (0.82, 1.36)  42 339 1.00 (0.56, 1.80) 
   20-24   61   412 0.99 (0.73, 1.34)  26 174 1.28 (0.61, 2.69) 
   ≥25   23   129 1.02 (0.62, 1.69)    9   84 1.01 (0.40, 2.53) 
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work duration. 
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Table 3.4 Female and male PSS score and fecundability, stratified by female age  
 Age <35 years  Age ≥35 years 
Exposure Pregnancies N 
Cycles 
N 
Adjusteda 
FR (95% CI)  
Pregnancies 
N 
Cycles 
N 
Adjusteda 
FR (95% CI) 
Female baseline PSS score      
   <10 297 1653 Reference  40 334 Reference 
   10-14 644 3915 0.96 (0.84, 1.09)  71 693 0.92 (0.69, 1.22) 
   15-19 601 3803 0.94 (0.83, 1.06)  75 687 0.95 (0.78, 1.17) 
   20-24 304 2116 0.91 (0.78, 1.06)  36 310 1.01 (0.84, 1.23) 
   ≥25 110   881 0.79 (0.64, 0.97)  15 122 0.94 (0.72, 1.24) 
Female time-varying PSS score      
   <10 314 1796 Reference  41 370 Reference 
   10-14 631 3736 0.98 (0.86, 1.11)  68 710 0.82 (0.56, 1.21) 
   15-19 597 3725 0.95 (0.84, 1.08)  77 611 1.06 (0.73, 1.55) 
   20-24 300 2167 0.88 (0.76, 1.03)  34 339 0.99 (0.65, 1.52) 
   ≥25 114   944 0.78 (0.64, 0.96)  17 116 1.17 (0.67, 2.04) 
Female cumulative average PSS score      
   <10 310 1698 Reference  41 373 Reference 
   10-14 641 3936 0.93 (0.82, 1.06)  68 731 0.82 (0.55, 1.20) 
   15-19 604 3813 0.93 (0.82, 1.05)  82 608 1.17 (0.81, 1.69) 
   20-24 303 2110 0.89 (0.77, 1.04)  32 333 0.96 (0.62, 1.50) 
   ≥25   98   811 0.74 (0.59, 0.92)  14 101 1.10 (0.60, 2.02) 
Male baseline PSS score      
   <10 123   770 Reference  20   87 Reference 
   10-14 192 1119 1.03 (0.80, 1.33)  20 191 0.94 (0.82, 1.08) 
   15-19 169 1054 1.08 (0.85, 1.35)  19 153 0.95 (0.82, 1.12) 
   20-24   79   513 1.12 (0.82, 1.54)    8   73 0.92 (0.77, 1.09) 
   ≥25   30   189 1.02 (0.67, 1.57)    2   24 0.92 (0.74, 1.15) 
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work duration. 
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Table 3.5 Baseline scores on individual PSS items and fecundability 
 Female PSS Items  Male PSS Items 
Exposure Pregnancies N 
Cycles 
N 
Adjusteda 
FR (95% CI)  
Pregnancies 
N 
Cycles 
N 
Adjusteda 
FR (95% CI) 
        
1. How often have you been upset because of something that happened unexpectedly?   
   Never     71   424 Reference    60   289 Reference 
   Almost never   527 3536 0.90 (0.72, 1.13)  198 1325 0.83 (0.62, 1.11) 
   Sometimes 1212 7886 0.95 (0.77, 1.18)  306 1880 0.91 (0.68, 1.20) 
   Fairly often   328 2245 0.91 (0.73, 1.15)    82   574 0.88 (0.58, 1.33) 
   Very often     55   423 0.89 (0.63, 1.24)    16   105 1.01 (0.56, 1.82) 
        
2. How often have you felt that you were unable to control the important things in your life?   
   Never   172 1023 Reference  100   545 Reference 
   Almost never   766 4792 0.97 (0.83, 1.12)  251 1535 0.86 (0.62, 1.21) 
   Sometimes   904 6231 0.92 (0.79, 1.07)  206 1331 0.84 (0.61, 1.15) 
   Fairly often   268 1900 0.93 (0.77, 1.12)    86   649 0.88 (0.63, 1.22) 
   Very often     83   568 0.97 (0.76, 1.25)    19   113 0.82 (0.49, 1.39) 
        
3. How often have you felt nervous and “stressed”?   
   Never       9     97 Reference    30   165 Reference 
   Almost never   168 1161 1.29 (0.77, 2.15)  130   854 0.88 (0.48, 1.62) 
   Sometimes   839 5635 1.33 (0.81, 2.19)  275 1743 0.96 (0.53, 1.74) 
   Fairly often   500 3555 1.23 (0.75, 2.02)  173 1037 0.96 (0.52, 1.77) 
   Very often   146 1157 1.19 (0.71, 1.99)    54   374 0.87 (0.44, 1.73) 
        
4. How often have you felt confident about your ability to handle your personal problems?   
   Never     10     63 1.08 (0.58, 2.00)      6       9 2.07 (0.83, 5.18) 
   Almost never     64   401 0.87 (0.68, 1.11)    20   147 1.12 (0.61, 2.04) 
   Sometimes   416 2940 0.93 (0.83, 1.05)  130   787 1.09 (0.87, 1.36) 
   Fairly often 1016 6847 0.94 (0.86, 1.03)  263 1757 0.96 (0.80, 1.15) 
   Very often   687 4263 Reference  243 1473 Reference 
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5. How often have you felt that things were going your way?   
   Never       8     43 0.98 (0.42, 2.29)      4     23 1.07 (0.38, 2.97) 
   Almost never     89   544 0.95 (0.76, 1.17)    35   256 1.10 (0.71, 1.71) 
   Sometimes   661 4778 0.86 (0.77, 0.97)  196 1311 0.95 (0.75, 1.20) 
   Fairly often 1027 6905 0.89 (0.80, 0.99)  290 1772 0.93 (0.75, 1.15) 
   Very often   408 2244 Reference  137   811 Reference 
        
6. How often have you found that you could not cope with all the things that you had to do?   
   Never   241 1480 Reference  123   736 Reference 
   Almost never   956 6135 0.97 (0.85, 1.10)  269 1725 1.00 (0.80, 1.26) 
   Sometimes   763 5183 0.96 (0.84, 1.09)  185 1238 0.94 (0.68, 1.29) 
   Fairly often   167 1307 0.85 (0.71, 1.02)    68   332 1.15 (0.86, 1.53) 
   Very often     66   409 0.96 (0.73, 1.28)    17   142 0.77 (0.45, 1.31) 
        
7. How often have you been able to control irritations in your life?   
   Never       5     52 0.60 (0.26, 1.40)      4     17 1.53 (0.61, 3.82) 
   Almost never   105   658 1.07 (0.87, 1.32)    28   248 0.86 (0.51, 1.43) 
   Sometimes   662 4910 0.92 (0.81, 1.04)  183 1285 1.11 (0.83, 1.48) 
   Fairly often 1087 6818 1.02 (0.91, 1.14)  312 1752 1.12 (0.91, 1.37) 
   Very often   334 2076 Reference  135   871 Reference 
        
8. How often have you felt that you were on top of things?   
   Never       7     30 1.69 (0.74, 3.87)      2     26 0.73 (0.17, 3.20) 
   Almost never   116   697 1.08 (0.89, 1.31)    48   272 0.97 (0.62, 1.51) 
   Sometimes   619 4397 0.98 (0.87, 1.10)  190 1178 1.03 (0.75, 1.41) 
   Fairly often 1067 6999 0.99 (0.89, 1.10)  291 1871 0.97 (0.76, 1.24) 
   Very often   384 2391 Reference  131   826 Reference 
        
9. How often have you been angered because of things that were outside your control?   
   Never     79   516 Reference    55   294 Reference 
   Almost never   599 3951 0.99 (0.80, 1.22)  201 1283 0.78 (0.52, 1.16) 
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   Sometimes 1176 7616 1.04 (0.85, 1.28)  294 1826 0.90 (0.66, 1.24) 
   Fairly often   275 1951 0.95 (0.75, 1.20)    92   643 0.93 (0.64, 1.34) 
   Very often     64   480 0.99 (0.73, 1.34)    20   127 0.84 (0.50, 1.38) 
        
10. How often have you felt difficulties were piling up so high that you could not overcome them?  
   Never   417 2469 Reference  139   837 Reference 
   Almost never 1003 6331 0.96 (0.86, 1.06)  286 1731 0.97 (0.77, 1.21) 
   Sometimes   593 4296 0.90 (0.81, 1.01)  181 1155 0.99 (0.77, 1.27) 
   Fairly often   135 1122 0.78 (0.65, 0.93)    40   339 0.97 (0.62, 1.52) 
   Very often     45   296 1.09 (0.81, 1.47)    16   111 0.89 (0.54, 1.47) 
        
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work duration. 
  
		 73 
Table 3.6 Combined female and male baseline PSS score and fecundability 
Exposure 
Pregs 
N 
Cycles 
N 
Unadjusted 
FR (95% CI) 
Adjusteda 
FR (95% CI) 
     
Couple PSS score     
   Both partners <10   38   187 Reference Reference 
   Female 10-19, male <10   86   488 0.93 (0.61, 1.41) 0.89 (0.56, 1.39) 
   Female ≥20, male <10   19   182 0.62 (0.33, 1.16) 0.60 (0.30, 1.20) 
   Female <10, male 10-19   66   390 1.04 (0.67, 1.60) 0.95 (0.58, 1.56) 
   Both partners 10-19 255 1526 0.93 (0.67, 1.29) 0.88 (0.60, 1.28) 
   Female ≥20, male 10-19   79   601 0.78 (0.53, 1.15) 0.76 (0.49, 1.17) 
   Female <10, male ≥20    14     69 0.94 (0.51, 1.74) 0.85 (0.43, 1.70) 
   Female 10-19, male ≥20   75   567 0.85 (0.56, 1.27) 0.84 (0.53, 1.33) 
   Both partners ≥20   30   163 1.08 (0.70, 1.67) 1.16 (0.75, 1.79) 
     
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work duration. 
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Table 3.7 Natural direct and indirect effects of female baseline PSS (≥25 vs. <25) on fecundability 
 Natural indirect 
effect 
FR (95% CI) 
Natural direct 
effect 
FR (95% CI) 
Proportion 
mediated 
% 
    
Sleep duration (<7 vs. ≥7 hours/night) 0.98 (0.94, 1.02) 0.88 (0.74, 1.04) 13.3 
Current smoker (yes vs. no) 1.01 (0.99, 1.03) 0.86 (0.73, 1.00)  -3.7 
Alcohol intake (≥14 vs. <14 drinks/week) 1.00 (0.99, 1.01) 0.87 (0.73, 1.01)   0.0 
Caffeine intake (≥300 vs.<300 mg/day) 1.00 (0.99, 1.02) 0.87 (0.73, 1.03)  -2.1 
MDI score (≥30 vs. <30) 0.99 (0.94, 1.06) 0.88 (0.72, 1.04)   5.8 
Intercourse frequency (<1 vs. ≥1 times/week) 1.00 (0.99, 1.01) 0.87 (0.73, 1.00)  -0.3 
Irregular cycles (yes vs. no) 0.99 (0.97, 1.02) 0.87 (0.72, 1.01)   4.6 
    
a Adjusted for age, BMI, race/ethnicity, education, income, employment status, and work duration.  
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Figure 3.1 Directed acyclic grah of the relationship between perceived stress and fecundability 
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Figure 3.1 Directed acyclic graph of the relationship between perceived stress and fecundability  
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Figure 3.2 Association between female and male baseline PSS score and fecundability, fit using restricted cubic splines   
The solid line represents the FR and the shaded area represents the 95% confidence band.  The reference level for the FR is a 
PSS score of 0.  The curves are adjusted for age, BMI, race/ethnicity, education, income, employment status, and work 
duration.  The splines are trimmed at the 99th percentile and have four knot points each at the 10th, 25th, 75th, and 90th 
percentiles.  
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4 PROSPECTIVE STUDY OF SMOKING AND FECUNDABILITY AMONG 
NORTH AMERICAN COUPLES 
4.1 INTRODUCTION 
 Despite substantial evidence implicating tobacco exposure in adverse fetal and 
neonatal health problems,1,2 cigarette smoking remains common during the preconception 
period.  In the 2010 U.S. Pregnancy Risk Assessment Monitoring System survey, 23.2% 
of women smoked during the three months before pregnancy.3  There was considerable 
geographic variability in preconception smoking, ranging from 9.2% in New York City to 
46.2% in West Virginia.  Smoking is one of the primary modifiable targets for 
preconception guidance,4 and a goal of the Healthy People 2020 initiative is to decrease 
the prevalence of smoking before pregnancy.5 
 Female active cigarette smoking was identified as a cause of infertility in the 2004 
Surgeon General’s Report on the Health Consequences of Smoking,1 citing evidence 
primarily from studies of infertile couples.  Data from preconception cohort studies 
generally support this conclusion,6-12 although there is inconsistency in the dose, duration, 
and recency of cigarette smoking at which a reduction in fecundability is observed.  
When examining intensity of smoking, studies have found adverse associations at 
amounts greater than 5,11 10,9 or 15 cigarettes/day,6 whereas others have found adverse 
associations at all levels of intensity,7,10 while others have not examined intensity.8,12  
There is also some evidence that smoking may affect fertility only after longer durations 
(≥10 years).11  Studies of the association between former smoking and fecundability are 
inconclusive: some have found no substantial association10,13 or an association only 
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among former smokers with the highest cumulative exposure.11   
Male active cigarette smoking, on the other hand, has not been identified as a 
causal factor in the etiology of infertility.1,2  Although moderate and heavy smoking has 
been associated with lower sperm count, motility, and morphology,14 and two 
preconception cohort studies have found strong associations between male partner 
smoking and reduced fecundability,10,12 others have found no substantial relation.7,9,11  
Most of these studies examined male partner smoking as a binary variable (current vs. 
not) and some relied on female report of male smoking.11  In addition, only one study has 
examined the relation of alternative forms of male tobacco exposure, such as chewing 
tobacco or snus, and fecundability.12 
The literature on female and male passive smoke exposure is also mixed.  The 
2006 Surgeon General’s Report on the Health Consequences of Involuntary Exposure to 
Tobacco Smoke reported inadequate evidence to infer a causal relation in females, and no 
data on males.15  In studies of rodents and rhesus monkeys, passive smoke exposure was 
associated with reduced semen quality and transport.16,17  Among couples undergoing 
fertility treatment, current female passive smoke exposure was associated with poorer in 
vitro fertilization outcomes.18-20  The extent to which early life passive smoke exposure 
influences fertility is unclear.  Some studies examining childhood or prenatal exposure to 
cigarette smoking have found substantial decrements in fertility,8,10,21 while others have 
found little association.11,22-24 
We used data from a large preconception cohort study of North American 
pregnancy planners to examine the influence of female and male active smoking on 
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fecundability, including characterization of dose and duration.  We also examined the 
effects of passive smoking throughout the life course on fecundability. 
4.2 METHODS 
4.2.1 Study design and population 
Pregnancy Study Online (PRESTO) is an ongoing internet-based preconception 
cohort study of North American pregnancy planners.25  Eligible female participants are 
21-45 years old, in a stable relationship with a male partner, residing in the United States 
or Canada, and not using contraception or fertility treatments.  Eligible male participants 
are ≥21 years old with a female partner already enrolled in PRESTO.  All participants 
complete an online baseline questionnaire on demographic, behavioral, lifestyle, medical, 
and reproductive characteristics.  Ten days after completion of the baseline questionnaire, 
participants complete a food frequency questionnaire (FFQ).26  Female participants 
additionally complete follow-up questionnaires every eight weeks for up to 12 months to 
ascertain pregnancy status and update exposure information.   
4.2.2 Exclusions 
From June 2013 through November 2017, 6,850 women completed the baseline 
questionnaire.  We excluded women with a baseline last menstrual period (LMP) date at 
least six months before study entry (n=76) or after study entry (n=10), or who had no 
prospective LMP dates over follow-up (n=5).  We additionally excluded 1,119 women 
who had been trying to conceive for more than six cycles at enrollment.  Of the 4,830 
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females remaining, 54.4% invited their male partners to participate, and 1,282 (48.8%) 
males enrolled.   
4.2.3 Assessment of active smoking 
We collected active smoking information for females and males on their 
respective baseline questionnaires; for females only, we collected active smoking 
information on the follow-up questionnaires.  We asked participants if they currently 
smoked cigarettes.  Response choices were “yes, on a regular basis (at least one cigarette 
per day)”, “yes, occasionally (not every day)”, and “no”.  We asked current regular 
smokers how many cigarettes/day they smoked (1-4, 5-9, 10-14, 15-19, 20-29, ≥30), the 
age at which they began smoking, and the presence and duration of any periods of 
smoking cessation since they started smoking.  We asked non-smokers and current 
occasional smokers if they had ever smoked regularly, and those who reported “yes” 
were asked how many cigarettes/day they smoked (same categories as above), for how 
many years they smoked regularly, and how old they were when they stopped smoking.  
We asked male participants if they used chewing tobacco or snus in the past month and, 
if so, how often. 
In addition to obtaining information on male smoking on the male baseline 
questionnaire, we also asked female participants at baseline if their male partner currently 
smoked and, if so, how many cigarettes/day he smoked. 
 On the follow-up questionnaires, females reported whether they had smoked 
cigarettes during the previous four weeks.  Women who reported smoking regularly over 
the previous four weeks were asked how many cigarettes/day they smoked. 
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4.2.4 Assessment of passive smoking 
We collected data on passive smoking history on respective baseline 
questionnaires for each partner.  We asked participants at which of the following ages 
they were in the same room as someone who was smoking for at least an hour per day for 
at least 12 consecutive months: 0-10, 11-20, 21-30, 31-40 years, and current.  For the 
latter three age ranges, we asked about passive smoke exposure at home and work 
separately.  We also asked female participants if their mothers smoked while pregnant 
with them, and if so, how many cigarettes they smoked per day (<10 or ≥10).  On follow-
up questionnaires, we asked women about current passive smoke exposure at home and 
work. 
4.2.5 Assessment of fecundability 
On the female follow-up questionnaires, we asked participants if they were 
currently pregnant and if they had had any intervening pregnancy losses since their last 
questionnaire.  We sought pregnancy information on women who were lost to follow-up 
by contacting participants via telephone, searching for baby announcements and registries 
online, and linking participant data with birth registry data in selected states or Fertility 
Friend data. 
 On the female baseline questionnaire, women reported the number of cycles they 
had been attempting pregnancy, their LMP date, whether their menstrual cycles were 
regular, and, if so, their usual cycle length.  For women who reported irregular cycles, we 
estimated usual cycle length using follow-up LMP data.  We calculated study time as 
follows: (menstrual cycles of attempt time at baseline) + [(LMP date from most recent 
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follow-up questionnaire - date of baseline questionnaire)/cycle length] + 1. 
4.2.6 Assessment of covariates 
On both female and male baseline questionnaires, we ascertained information on 
demographics (age, race/ethnicity, education, employment, geographic region of 
residence), lifestyle/behavior (physical activity, alcohol use, caffeine intake, marijuana 
use, sugar-sweetened beverage intake, sleep duration, multivitamin and folic acid intake), 
medical history (history of depression and anxiety, perceived stress scale (PSS),27 major 
depression inventory (MDI),28 current height and weight, history of sexually transmitted 
infections (STI)), and reproductive factors (history of infertility, pregnancy (females) and 
having ever impregnated one’s partner (males)).  On the female baseline questionnaire, 
we collected information on marital status, annual household income, history of pap 
testing, menstrual cycle regularity and length, intercourse frequency, doing something to 
improve chances of conception (e.g., timing intercourse, using ovulation predictor kits, 
checking basal body temperature), and contraceptive history.  We calculated the Healthy 
Eating Index (HEI) score from the FFQ.29   
4.2.7 Statistical analysis 
Women contributed observed menstrual cycles of attempt time from study entry 
until pregnancy, initiation of fertility treatment, cessation of pregnancy attempt, loss to 
follow-up, or 12 cycles, whichever came first.  We calculated the proportion of couples 
who conceived over follow-up using life-table methods.  We used the Anderson-Gill data 
structure with one observation per cycle to account for left truncation30,31 and to update 
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exposure and covariates over time.32  We fit proportional probabilities regression models 
to examine the association between smoking and fecundability.8  This model estimates 
the fecundability ratio (FR), the average per cycle probability of conception in exposed 
compared with unexposed participants, and 95% confidence intervals (CI).  We included 
indicator variables for cycle at risk in the model to account for the decline in baseline 
fecundability over time. 
 We compared fecundability among current regular, current occasional, and former 
smokers with that of never smokers, separately in females and males.  Among current 
smokers, we examined fecundability within categories of intensity (<5, 5-9, ≥10 
cigarettes/day) and duration (<10, ≥10 years).  Rather than examining pack-years of 
smoking, a variable which combines information on intensity and duration, we examined 
joint categories of intensity and duration in order to elucidate which factor was more 
strongly associated with fecundability.  Among former smokers, we examined 
fecundability within categories of intensity (<5, 5-9, ≥10 cigarettes/day) and duration 
(<10, ≥10 years), as well as time since smoking cessation (<1, 1, 2-4, ≥5 years).  Because 
of the strong association between duration of smoking and age, we restricted analyses of 
duration and fecundability to individuals aged 25-34 years.  In male participants, we 
examined the association between current use of chewing tobacco or snus, including 
intensity of use, and fecundability. 
As male and female reports of smoking are both subject to misclassification, and 
neither can be considered the gold standard, we evaluated the agreement between the two 
measures.  Our primary analysis of male active smoking and fecundability used male-
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reported smoking information.  We conducted a sensitivity analysis using female-
reported male smoking information.   
We examined the relation of current and lifetime passive smoke exposure and 
fecundability among never smokers.  Specifically, we examined childhood, adolescent, 
adulthood, and current passive smoke exposure, as well as in utero smoke exposure 
among female participants.  We also examined current passive smoke exposure and 
current partner smoking jointly, to determine whether any observed association was due 
to passive smoke exposure or partner active smoking. 
 We identified confounders a priori based on a literature review and construction 
of a directed acyclic graph (Figure 4.1).  Final models were adjusted for age (<25, 25-29, 
30-34, ≥35 years), race/ethnicity (white non-Hispanic vs. Hispanic or non-white), 
education (<college degree, college degree, graduate school), annual household income 
(<$50,000, $50,000-$99,999, ≥$100,000), BMI (<25, 25-29, 30-34, ≥35 kg/m2), sugar-
sweetened beverage intake (0, 1, 2-6, ≥7 drinks/week), alcohol intake (0, 1-6, 7-13, ≥14 
drinks/week; males only), HEI score (<60, 60-69, 70-79, ≥80; females only), daily 
multivitamin or folic acid intake (yes, no), sleep duration (<7, 7-8, ≥9 hours/night), PSS 
score (<15, 15-19, 20-24, ≥25), MDI score (<20, 20-24, 25-29, ≥30), parity (0, ≥1), 
intercourse frequency (<1, 1-3, ≥4 times/week), doing something to improve chances of 
conception (yes, no), and current partner smoking.  We examined the effect of adjusting 
for physical activity, marijuana use, caffeine intake, employment status, geographic 
region of residence, history of spontaneous abortion, and occupational environmental 
exposures, but found no substantial confounding by these variables, so we omitted them 
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from final models.  
 To reduce bias from reverse causation, we stratified final models by attempt time 
at study entry (<3 vs 3-6 cycles).  We also examined whether the association between 
smoking and fecundability was stronger among older couples, potentially more subfertile 
(female age at baseline ≥30 years). 
 We conducted a probabilistic bias analysis to quantify the effect of under-
reporting of smoking on our results.33  Because smoking history was ascertained before 
pregnancy, we assumed that exposure misclassification was non-differential.  We defined 
bias parameters across the following six baseline smoking categories: never, former, 
current occasional, and current regular 1-4 5-9, and ≥10 cigarettes/day.  We assumed that 
women would under-report smoking by one category (e.g., current occasional smokers 
may report that they are former smokers).  We defined trapezoidal probability 
distributions for this under-reporting, with a range of 0-10% and lower and upper modes 
of 2.5% and 7.5%.  We assumed 100% specificity, as women are unlikely to over-report 
their smoking behaviors.  We sampled from this distribution 1,000 times, separately by 
pregnancy (assuming a correlation of 0.8), and calculated positive and negative predictive 
values.  We used these values to calculate a corrected data set and estimate adjusted FRs 
for each iteration. 
 Smoking history was strongly related to the probability of loss to follow-up 
(proportions among current regular, current occasional, former, and never smokers were 
46.4%, 34.2%, 26.6%, 23.0%, respectively).  We used inverse probability of continuation 
weights to account for differential loss to follow-up.13,34-36  We developed models 
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predicting continuation in the study at each observed menstrual cycle using pooled 
logistic regression, conditional on remaining in the study at the previous menstrual cycle.  
We included both time-varying (alcohol intake, daily multivitamin or folic acid intake, 
current marijuana use, PSS score, physical activity) and baseline (smoking intensity and 
duration, age, BMI, HEI score, race/ethnicity, marital status, geographic region of 
residence, annual household income, education, employment status, hours/week of work, 
exposure to occupational hazards, average sleep duration, parity, doing something to 
improve chances of conception, MDI score, pap smear in past three years, history of 
abnormal pap smear, attempt time at study entry, male partner participation status, and 
completion of the FFQ) variables.  We ran a separate pooled logistic regression model 
using baseline independent variables.  We calculated the predicted probabilities from 
these models and used them to calculate stabilized weights, which are inversely 
proportional to the probability of remaining in the study at each cycle.  Stabilized weights 
had a mean of 1.09 and ranged from 0.09 to 10.08.  We applied the stabilized weights to 
the proportional probabilities regression models.  The weighted results represent a 
pseudo-population where there is no loss to follow-up. 
We used a Markov chain Monte Carlo method to multiply impute missing 
outcome, exposure, and covariate data.37  We generated five imputation data sets and 
combined point estimates and standard errors from each data set.  For the 604 women 
with no follow-up data, we assigned them one cycle of follow-up and imputed their 
pregnancy status.  Fewer than 1% of all exposure variables were missing for smoking 
history; missingness was greater for passive smoke exposure in utero (16.5%), from age 
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0-10 years (6.1%) and from age 11-20 years (5.0%).  Covariate missingness ranged from 
0% (age) to 49.0% (male PSS score, which was added to the questionnaire in January 
2015). 
4.3 RESULTS 
 Over 53 months of follow-up, 4,830 female participants were followed for 19,071 
menstrual cycles; 1,282 male participants had female partners who were followed for 
5,264 menstrual cycles.  Overall, 70.5% of women conceived over follow-up (72.7% in 
the sample where the male partner participated).  Out of 2,743 pregnancies, 2,214 were 
self-reported on a follow-up questionnaire, 159 were imputed among women with no 
follow-up, and 370 were identified via other methods (e.g., birth registry linkage).  
Among the 2,087 women with no evidence of pregnancy, 335 (6.9%) initiated fertility 
treatment, 43 (0.9%) stopped trying to conceive, 692 (14.3%) were censored at 12 
menstrual cycles, 290 (6.0%) were still participating in the study and 727 (15.1%) were 
lost to follow-up.   
 At baseline, 24.9% of women and 29.3% of men were ever smokers.  Current 
smoking (regular or occasional) was more common among men (11.9%) than women 
(9.9%).  Over a quarter of current smokers consumed ≥10 cigarettes/day (28.7% of 
female smokers and 32.0% of male smokers), and the average duration of smoking 
among current regular smokers was 11.6 years for females and 13.8 years for males.  
Only 4.4% of men reported using chewing tobacco or snus, but use was more common 
among current occasional (9.1%) and former (7.2%) smokers.  Almost 8% percent of 
females and 11.9% of males reported current passive smoke exposure.  Passive smoke 
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exposure was more common in childhood (31.4% for females and 31.3% for males) than 
in adolescence (25.6% and 26.4%, respectively) or adulthood (20.5% and 25.0%, 
respectively).  In utero smoke exposure was reported among 13.1% of females.   
 Only 1.9% of women reported a change in their smoking behaviors over follow-
up.  Among 3,626 never smokers at baseline, nine (0.2%) initiated smoking over follow-
up (all occasional smokers).  Among 723 former smokers at baseline, 21 (2.9%) became 
occasional smokers and four (0.6%) became regular smokers.  Twenty-eight (14.7%) 
occasional smokers at baseline quit smoking over follow-up, whereas 12 (6.3%) became 
regular smokers.  Only 11 (3.8%) current regular smokers at baseline decreased their 
cigarette consumption over follow-up: 10 remained regular smokers but decreased their 
number of cigarettes/day and one quit smoking.  Seven (2.4%) regular smokers increased 
their cigarette consumption over follow-up. 
 Current regular smoking was strongly associated with partner smoking and both 
current and lifetime passive smoke exposure (Table 4.1).  Female current regular smokers 
had longer attempt times at study entry; higher BMI; higher caffeine, alcohol, and sugar-
sweetened beverage intakes; higher MDI scores; and were more likely to smoke 
marijuana; have short sleep durations; have a history of STI, pelvic inflammatory disease, 
or infertility; be gravid and parous; have irregular cycles; have frequent intercourse; and 
reside in Canada or the Midwestern or Southern United States.  Smokers also tended to 
report lower education levels and income, lower HEI scores, less physical activity, and 
were less likely to take daily multivitamins or folic acid and to be doing something to 
improve chances of conception.  Associations between smoking and covariates were 
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relatively similar among males, although male smokers were more likely to be non-
Hispanic white than non-smokers. 
4.3.1 Female active smoking and fecundability 
Although the unadjusted analysis showed a 16% reduction in fecundability among 
current regular smokers compared with never smokers, after adjusting for confounders, 
female current regular smoking was not associated with reduced fecundability (Table 
4.2).  Education, income, BMI, sugar-sweetened beverage intake, HEI score, and parity 
were the strongest confounders of the association.  The FR for women smoking ≥10 
cigarettes/day compared with never smokers was 0.94 (95% CI: 0.71, 1.25).  Results 
were slightly stronger among women who smoked for ≥10 years (FR=0.88, 95% CI: 
0.68, 1.16).  Women who smoked ≥10 cigarettes/day for ≥10 years had the lowest 
fecundability (FR compared with never smokers=0.78, 95% CI: 0.58, 1.17).  Weighting 
the models using the inverse probability of continuation weights shifted the estimates 
downwards: FRs for ≥10 cigarettes/day and ≥10 years of regular smoking compared with 
never smokers were 0.93 (95% CI: 0.70, 1.22) and 0.82 (95% CI: 0.63, 1.06). 
Former smokers had slightly lower fecundability than never smokers (FR=0.93, 
95% CI: 0.84, 1.04; Table 4.2).  The association was strongest among women who had 
smoked with the greatest intensity (FR for ≥10 cigarettes/day vs. never smokers was 0.90, 
95% CI: 0.77, 1.06).  The association did not differ substantially by duration of smoking 
(FRs for <10 and ≥10 years were 0.94 and 0.96), and was not stronger among women 
who had quit most recently.  Weighted models were slightly stronger (FR comparing 
former with never smokers=0.90, 95% CI: 0.81, 1.00). 
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 Results for time-varying female active smoking and fecundability were similar to 
the baseline only results.  FRs for current regular smoking <5, 5-9, and ≥10 cigarettes/day 
compared with never smokers were 1.20 (95% CI: 0.88, 1.63), 1.00 (95% CI: 0.72, 1.39), 
and 0.91 (95% CI: 0.68, 1.22), respectively. 
 Inverse associations between female active smoking and fecundability were 
generally stronger among women who had been attempting to conceive for <3 menstrual 
cycles at study entry (Table 4.3).  We found little evidence of a stronger association 
between female active smoking and fecundability among women ≥30 years of age (Table 
4.4). 
 The exposure misclassification simulation resulted in 1,000 corrected FRs for 
each category of current smoking (<1, 1-4, 5-9, and ≥10 cigarettes/day) relative to never 
smokers.  The median and 95% simulation intervals were 0.91 (0.88, 0.94), 1.16 (1.08, 
1.25), 0.96 (0.91, 1.02), and 0.94 (0.91, 0.97), respectively. 
4.3.2 Female passive smoking and fecundability 
Current exposure to passive smoke (Table 4.5) was not associated with substantial 
reductions in fecundability among never smoking females (FR=0.94, 95% CI: 0.74, 
1.19).  When jointly examining categories of female passive smoking and partner current 
active smoking, only female never smokers who reported passive smoke exposure and 
whose partners were current smokers had reduced fecundability (FR=0.69, 95% CI: 0.45, 
1.06); passive smoke exposure from partners only (FR=0.96, 95% CI: 0.75, 1.22) or other 
sources only (FR=1.10, 95% CI: 0.81, 1.49) was not substantially associated with 
fecundability. 
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Passive smoking throughout the life course was not substantially associated with 
fecundability.  However, never smoking women reporting in utero exposure to ≥10 
cigarettes/day had slightly lower fecundability than unexposed women (FR=0.86, 95% 
CI: 0.60, 1.23).  In utero exposure to 1-10 cigarettes/day was not substantially associated 
with fecundability (FR=1.04, 95% CI: 0.86, 1.26). 
Results for time-varying current passive smoking were similar to baseline results: 
the FR for current passive smoking among never smokers was 0.94 (95% CI: 0.75, 1.17). 
Among never smoking women, the association between current passive smoking and 
fecundability was slightly stronger among those attempting conception for 3-6 cycles at 
study entry (FR=0.86, 95% CI: 0.57, 1.31) than among those attempting conception for 
<3 cycles (FR=0.97, 95% CI: 0.73, 1.28).  The association was also stronger among older 
women (FR for women age ≥30 years=0.82, 95% CI: 0.48, 1.41; FR for women age <30 
years=1.00, 95% CI: 0.68, 1.46). 
When we examined lifetime history of active and passive smoking (Table 4.10), 
the strongest inverse association was for women with no early life passive smoking, adult 
passive smoking, and former active smoking (FR=0.81, 95% CI: 0.65, 1.02).  There was 
little evidence of a dose-response relation between cumulative exposure to active and 
passive smoking throughout the life course and fecundability.  
4.3.3 Male active smoking and fecundability 
Male active smoking was associated with small decrements in fecundability 
(Table 4.6), and findings were stronger among men who smoked 5-9 (FR=0.81, 95% CI: 
0.39, 1.65) or ≥10 (FR=0.76, 95% CI: 0.46, 1.25) cigarettes/day than among men who 
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smoked <5 cigarettes/day (FR=1.41, 95% CI: 0.68, 2.92).  There was no clear pattern for 
duration of current smoking with fecundability, but results were imprecise.  Former 
smoking in men was associated with improved fecundability compared with never 
smoking (FR=1.23, 95% CI: 1.02, 1.47; Table 4.6).  This relation was strongest for men 
who had quit smoking within 1 year (FR=1.70, 95% CI: 0.98, 2.97), who had smoked 
≥10 cigarettes/day (FR=1.24, 95% CI: 0.93, 1.65), and who had smoked for ≥10 years 
(FR=1.40, 95% CI: 0.97, 2.03).   
 The inverse association between male current smoking and fecundability was 
stronger among couples who had been attempting conception for <3 cycles at study entry. 
The FR for current occasional and current regular smokers were 0.83 (95% CI: 0.56, 
1.22) and 0.64 (95% CI: 0.40, 1.02), respectively.  In contrast, the positive association 
between male former smoking and fecundability was not as strong in this group 
(FR=1.11, 95% CI: 0.89, 1.38).  
 There was good agreement between men and women’s reports of male partner 
current smoking (Table 4.7).  Within three categories of exposure (current regular, 
current occasional, and not current), 94.4% of couples reported identically.  When asked 
to report the intensity of their male partners’ cigarette smoking (in four categories), exact 
agreement remained high (92.9%), but when restricted to couples where the male 
reported any current smoking, agreement was lower (51.0% of couples reported 
identically; 94.1% reported within one category).  We found higher agreement between 
female and male report when the male partners reported being non-smokers (96.4%) or 
high intensity smokers (92.1%).   
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When using male report of smoking intensity, FRs comparing current smoking 
<1, 1-4, 5-9, and ≥10 cigarettes/day with not current smoking were 0.82 (95% CI: 0.60, 
1.12), 1.32 (95% CI: 0.60, 2.90), 0.84 (95% CI: 0.42, 1.66), and 0.77 (95% CI: 0.48, 
1.24), respectively (Table 4.8).  When using female report of male smoking intensity, the 
respective FRs were 1.01 (95% CI: 0.73, 1.39), 0.60 (95% CI: 0.28, 1.28), 0.97 (95% CI: 
0.51, 1.88), and 0.71 (95% CI: 0.42, 1.21) in the sample where the male participated, and 
0.92 (95% CI: 0.78, 1.08), 0.75 (95% CI: 0.55, 1.01), 1.04 (95% CI: 0.79, 1.35), and 0.83 
(95% CI: 0.68, 1.03) in the full sample. 
The FRs for men who reported using snus or chewing tobacco 1-6 times/week and 
≥7 times/week were 1.29 (95% CI: 0.86, 1.95) and 0.77 (95% CI: 0.47, 1.29), 
respectively, relative to non-users. 
4.3.4 Male passive smoking and fecundability 
Male passive smoke exposure within the year before baseline or throughout the 
life course was not substantially associated with fecundability among never smokers 
(Table 4.9).  Likewise, there was little evidence of an association between cumulative 
exposure to active and passive smoking throughout the life course and fecundability 
(Table 4.10). 
4.4 DISCUSSION  
 In this preconception cohort study of North American pregnancy planners, we 
found small reductions in fecundability for current female smokers who had smoked for 
at least 10 years and with greater intensity.  Former female smokers also had slightly 
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lower fecundability, but neither intensity nor duration of former smoking were clearly 
related to fecundability.  Among men, current smoking was associated with stronger 
reductions in fecundability than in women, but male former smokers had higher 
fecundability than never smokers which was attenuated among couples who had been 
trying for shorter times at study entry.  Passive smoking was not substantially associated 
with fecundability in either partner, but women exposed in utero to high intensity 
smoking had lower fecundability than those not exposed in utero.   
 Studies of infertile couples show a consistent adverse effect of female active 
smoking on fertility treatment outcomes.1  Preconception cohort studies6-12 have 
supported this observation, although the size of the association and the intensity at which 
an association is observed have varied considerably across studies.  Our findings of an 
overall near null association between female current regular smoking and fecundability, 
and only small reductions in fecundability among current smokers with the highest 
intensity and longest duration, are inconsistent with the overall picture.  Previous studies, 
however, were conducted between 19686 and 2011,11 compared with our more 
contemporary cohort (enrollment 2013-2017).  Given the secular decline in prevalence 
and intensity of smoking in the U.S.,38 and the observations from several studies that 
active smoking is associated with fecundability only at high intensities,6,9,11 our 
comparatively weak findings may reflect lower intensity smoking in our cohort.  For 
example, in the Oxford Family Planning Association contraceptive study conducted from 
1968-1974, 13.0% of women smoked at least 10 cigarettes/day, and FRs for 1-5, 6-10, 
11-15, 16-20, and >20 cigarettes/day were 1.00, 0.97, 0.93, 0.79, and 0.78, respectively.6  
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In PRESTO, only 2.9% of women smoked at least 10 cigarettes/day, and we were unable 
to break out the highest intensity category into finer levels due to small numbers. 
 Female active smoking history was strongly related to loss to follow-up in 
PRESTO.  If smoking women who do not conceive are disproportionately 
underrepresented in our analysis, their underrepresentation would result in an upward 
bias.  Other studies on smoking and fecundability have identified differential loss-to-
follow-up as a potential source of bias.11,12 In PRESTO we correct for this bias using 
inverse probability of continuation weights.  After correcting, we observed slightly 
stronger inverse associations between female active smoking and fecundability, 
consistent with the hypothesized direction of bias.  Nevertheless, this bias does not 
explain the difference between our results and those of earlier studies, because failing to 
correct for differential loss to follow-up is expected to result in weaker associations.   
 We quantified bias due to under-reporting of smoking intensity using a 
probabilistic bias analysis.  We expected that non-differential misclassification of a multi-
level exposure variable would result in bias towards the null in the extreme exposure 
categories, which could account for our weak findings.  However, simulated and 
observed FRs were similar, and the simulation intervals varied only slightly around the 
median, indicating that non-differential misclassification of exposure is unlikely to have 
had a strong enough influence to dilute a strong association to the level that we observed. 
 We found that controlling for a wide range of potential confounders, including 
demographic, lifestyle, behavioral, dietary, medical, and reproductive factors, 
substantially attenuated our findings, indicating a large amount of confounding.  In 
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addition to socioeconomic variables like education and income, BMI and dietary factors 
(sugar-sweetened beverage intake, HEI score) contributed to the attenuation of our results 
in adjusted models.  While these variables are not causes of smoking, they do help 
control for a latent “healthy lifestyle” variable: women who smoke are also more likely to 
make other unhealthy choices such as eating a poor diet.  No previous studies on this 
topic have controlled for dietary factors, and some have not controlled for socioeconomic 
factors, BMI, or parity.  Thus, residual confounding by incomplete control for healthy 
lifestyle may explain part of the inconsistency between our study and others. 
 We found no substantial association between current female passive smoking and 
fecundability.  Studies of couples undergoing fertility treatment report mixed results, with 
some showing no association between passive smoking and fertility,39,40 while others 
found that passive smoking is adversely associated with IVF outcomes.18-20  One such 
study19 even indicated that passive smoking was as damaging as active smoking to 
fertility, citing biologic evidence that passive smoking, rather than active smoking, is a 
primary determinant of exposure to polycyclic aromatic hydrocarbons,41 a component of 
cigarette smoke with suspected reproductive toxicity.42  However, a preconception cohort 
study of Danish pregnancy planners reported only an 8% reduction in fecundability 
among never smokers exposed to passive smoking in adulthood.11  Our findings may 
have been attenuated by exposure misclassification, specifically if the biologic window of 
susceptibility is narrower than we were able to measure (e.g., if exposure during 
ovulation or implantation is more relevant than exposure over the past year).  In addition, 
we did not collect information on the intensity of passive smoking.  If passive smoking 
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adversely affects fertility after a certain number of hours per day of exposure, but not at 
lower levels, our results would be biased towards the null.  Passive smoke exposure may 
be more intense when it comes from a male partner or other member of the household 
than when it comes from someone else.  This possibility could explain our finding of an 
association between passive smoke exposure and lower fecundability only among female 
never smokers whose partner was a current smoker. 
 We observed an inverse association between in utero smoke exposure and 
fecundability among women whose mothers smoked ≥10 cigarettes/day during 
pregnancy.  Preconception cohort studies have not examined intensity of maternal 
smoking in pregnancy, and have rather classified exposure as any vs. none.  Those 
studies published before 1990 have found inverse associations between in utero smoke 
exposure and fecundability,8,10 whereas a more recent study found no substantial 
association.11  These discrepancies may reflect decreased smoking intensity 
(cigarettes/day) over time, with the “any” category in earlier studies including more 
mothers with high intensity smoking than later studies.  In utero smoke exposure, in 
particular intensity of exposure, is prone to misclassification; while we expect that results 
in the high intensity category are biased towards the null, bias in the low intensity 
category may be towards or away from the null.  
 Our examination of active and passive smoking from the prenatal through 
preconception periods allows for detailed hypotheses as to potential biologic mechanisms 
through which cigarette constituents may affect fertility.  Our finding of similar declines 
in fecundability for current and former smokers and the strongest associations among 
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those who smoked ≥10 cigarettes/day for ≥10 years indicates that cumulative exposure to 
cigarettes may be more important than acute exposure around the time of the conception 
attempt.  Cigarette smoke contains approximately 4,000 compounds, including polycyclic 
aromatic hydrocarbons, heavy metals, and alkaloids.  Animal studies have demonstrated 
that some of these compounds are ovotoxic.43  Exposure can cause apoptosis in 
primordial oocytes,44 alter folliculogenesis,45 impair follicle growth,46 and affect oocyte 
growth and development.47  In humans, smoking has been associated with premature 
ovarian failure,48 early menopause,49-51 and lower antimullerian hormone levels, a 
biomarker of ovarian reserve.52-55  Smoking may also have a chronic effect on fertility by 
increasing susceptibility to STIs and harming tubal function through structural and 
functional changes.56,57 Although we did observe a higher prevalence of STIs among 
current and former smokers compared with never smokers, controlling for history of STIs 
did not substantially alter our associations, suggesting that presence of an STI is not a 
strong mediator. 
 We observed reduced fecundability among male current smokers, particularly 
among heavier smokers.  Our findings were weaker than, but in the same direction as, 
findings from two preconception cohort studies,10,12 but other studies found no substantial 
association7,11 or a positive association.9  Interestingly, we observed that former smoking 
among men was associated with improved fecundability, although results were attenuated 
among couples who had been trying to conceive for <3 cycles.  These findings may 
reflect unmeasured confounding: men who have quit smoking may also practice other 
healthy behaviors that we were unable to control for.  We did not observe improved 
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fecundability among female former smokers, where we would expect the same level of 
unmeasured confounding, although we did see slightly improved fecundability among 
women who had quit most recently.  
 Overall, we found high agreement between male and female report of male 
current smoking status, but lower agreement on smoking intensity.  This pattern is 
consistent with results from the Avon Longitudinal Study of Pregnancy and Childhood58 
and a cohort of obstetric patients at New Jersey hospitals.59  Both studies found high 
agreement between male and female report of male smoking status, but weaker 
agreement in report of smoking intensity.  Most of this error is likely due to differences in 
reporting (either because the female partner does not know how much her male partner 
smokes, or either the female or male under-report smoking intensity).  However, because 
the female and male baseline questionnaires were not completed at the same time 
(median difference of 1 day, range: 0-736 days, 76.7% within one week), some 
disagreement could result from true change in smoking intensity over time.  Given the 
small amount of change in smoking behavior over follow-up we observed in the females, 
we expect this type of error to be small.   
 We observed lower fecundability among men who used chewing tobacco or snus 
on a daily basis compared with non-users, after controlling for smoking history.  This 
finding disagrees with the only study on this topic that found no association between 
smokeless tobacco use and fecundability among 501 pregnancy planning couples.12  
However, our results are imprecise due to a small number of daily chewing tobacco or 
snus users. 
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 Our finding of an inverse association between fecundability and male current 
smoking, but not former smoking indicates that, if causal, the effect of smoking on 
fecundability is short term.  This characteristic is consistent with results from a recent 
meta-analysis supporting the hypothesis that smoking adversely affects sperm count, 
motility, and morphology.14  The toxic compounds in cigarette smoke have demonstrated 
the ability to decrease the mitochondrial activity and impair chromatin structure in sperm, 
resulting in impaired fertilization capacity.60,61  Smoking also results in oxygen 
insufficiency, which can interfere with spermatogenesis.62  Nicotine can disrupt the 
hypothalamic-pituitary-gonadal axis by altering concentrations of endogenous hormones 
including luteinizing hormone, follicle-stimulating hormone, and testosterone.63,64  
Lastly, smoking has been identified as a cause of erectile dysfunction,2 and smoking 
cessation is associated with improved sexual health.65  
Our study was restricted to couples planning a pregnancy.  If smokers are more 
likely to have unintended pregnancies relative to non-smokers because of differences in 
type and consistent use of birth control, as hypothesized by some researchers,66 our 
cohort would enroll less fertile smokers, resulting in an exaggerated inverse association 
between smoking and fecundability.  However, because our observed inverse associations 
were small, this phenomenon is unlikely to be a substantial source of bias.  In analyses 
restricted to couples attempting pregnancy for <3 cycles at study entry, we observed 
similar (female) and slightly stronger (male) associations for current active smoking.  In 
addition, we did not observe large differences in last method of birth control based on 
smoking history, although smoking history was strongly related to history of unplanned 
		
111 
pregnancy. 
Recruitment via the internet has been criticized because users of the internet differ 
from non-users.  However, this difference would only cause selection bias if the 
association between smoking and fertility also differed for internet users and non-users.  
Several studies have demonstrated that even when participation at study entry is 
associated with demographic or behavioral characteristics, measures of association are 
not necessarily biased by self-selection.67-69  In addition, we attempted to limit the 
amount of selection bias by including couples with shorter attempt times at study entry 
and women with no follow-up data. 
This study adds to the extensive body of literature on smoking and fertility.  We 
found that current active smoking at high intensity was associated with lower 
fecundability in both partners, particularly males.  We quantified two sources of bias 
commonly encountered when studying this relation, exposure misclassification and 
differential loss to follow-up, and found that neither source of bias resulted in large 
changes in measures of association.  We also observed that in utero smoke exposure 
among females was associated with reduced fecundability, but that passive smoking 
throughout the life course was not associated with fecundability in either partner.  
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4.5 TABLES & FIGURES 
Table 4.1 Baseline characteristics of female and male pregnancy planners by active smoking status 
 Female smoking history (n=4,830) Male smoking history (n=1,282) 
 
Characteristica 
Never 
n=3626 
 
Former 
n=723 
Current 
occasional 
n=190 
Current 
regular 
n=291 
Never 
n=907 
 
Former 
n=222 
Current 
occasional 
n=77 
Current 
regular 
n=76 
Proportion of participants     75.1   15.0       3.9     6.0   70.8     17.3       6.0     5.9 
Age (years), mean     29.9   31.2     30.1   29.2   31.3     33.2     32.0   32.5 
Partner’s age (years), mean     31.8   32.5     32.1   32.3   29.9     29.9     29.7   29.4 
Cycles of attempt time at study entry, mean       2.0     2.2       2.3     2.9     1.8       2.1       2.0     2.4 
Partner is current smoker, %       5.4     9.7     29.7   61.7     1.9       1.2       2.8   28.0 
Current passive smoke exposure, %       4.8     7.1     14.3   44.9     8.5     15.6     12.6   39.0 
Passive smoke exposure age 0-10, %     27.6   37.1     43.2   57.4   28.3     33.9     37.7   48.9 
Passive smoke exposure age 11-20, %     20.5   35.4     38.7   58.4   22.4     34.8     27.0   44.8 
Passive smoke exposure age 21-40, %     12.5   37.6     40.0   65.7   18.7     36.0     31.9   52.7 
Prenatal smoke exposure, %     10.3   15.2     23.5   34.6 -- -- -- -- 
Current use of chewing tobacco or snus, % -- -- -- --     3.4       7.5       9.7     3.1 
Smoking duration (years), mean       0.0     6.0       5.4   11.9     0.0       7.1       4.8   13.5 
White, non-Hispanic, %     83.9   86.2     80.5   85.3   85.8     86.3     87.2   90.3 
<College degree, %     17.7   36.4     44.3   59.9   23.6     37.5     32.6   74.4 
Annual household income <$50,000, %     15.8   19.2     25.4   46.5   13.8     18.9     20.3   44.2 
BMI (kg/m2), mean     26.8   28.6     28.6   29.1   27.3     28.4     30.6   28.1 
Physical activity (MET-hrs/wk), mean     36.0   34.0     37.6   29.6   34.4     33.3     28.2   24.8 
Current alcohol consumption (dr/wk), mean       3.0     4.2       6.2     3.8     5.0       7.6     10.2   11.8 
Current caffeine intake (mg/day), mean   105.4 143.4   160.3 233.0 155.1   204.8   232.9 277.4 
Current marijuana use, %       8.2   22.8     25.3   26.2     9.8     23.8     26.0   45.1 
Sugar-sweetened beverage intake (dr/wk), 
mean       2.4     2.6       4.5     7.3     3.8       4.5       4.7   12.9 
Healthy Eating Index score, meanb     67.4   65.7     64.2   55.8   63.0     62.6     62.2   50.9 
Daily multivitamin or folic acid intake, %     82.4   80.1     79.4   54.8   36.0     36.0     32.9   20.8 
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Sleep duration <7 hours/night, %     21.4   26.2     27.2   35.5   31.1     37.9     45.0   49.9 
Unemployed, %       2.8     6.1       6.8     9.9     3.0       5.1       1.7     4.8 
Work ≥50 hrs/wk, %c     13.4     9.9     12.9   12.1   31.0     29.4     19.2   29.0 
PSS score, mean     15.6   16.6     16.4   17.1   14.2     15.7     15.2   16.9 
MDI score, mean       9.5   11.4     12.8   13.9     8.8     10.0     10.5   12.4 
Gravid, %     43.2   55.9     58.3   71.0   41.2     42.3     40.6   59.8 
Parous, %     26.8   33.2     26.5   49.1    --      --      --    -- 
History of unplanned pregnancy, %     22.4   39.5     48.9   61.4    --      --      --    -- 
History of STI, %     10.4   18.2     18.5   20.8     5.1       4.5       6.5     2.1 
History of infertility, %       6.6     8.8       7.6   21.7     7.1       9.6       6.5   17.2 
Irregular cycles, %     15.8   17.2     14.7   20.2    --      --      --    -- 
Menstrual cycle length (days), mean     30.0   29.7     29.3   29.9    --      --      --    -- 
Intercourse frequency <1 time/week, %     21.6   20.7     19.5   17.4   21.4     19.3     14.4   19.7 
Intercourse frequency ≥4 times/week, %     14.3   18.9     22.6   24.8   14.6     17.8     15.3   23.9 
Doing something to improve chances, %     75.1   76.8     73.8   69.8   76.1     76.8     76.3   75.6 
Hormonal last method of contraception, %     39.4   38.6     40.8   39.0   34.9     36.6     45.5   40.8 
Geographic region of residence, %         
   U.S. Northeast     28.6   25.7     19.3   19.1   32.0     27.5     27.8   18.3 
   U.S. South     23.0   23.8     31.6   28.7   21.5     19.3     34.2   18.4 
   U.S. Midwest     17.3   16.5     18.6   24.0   16.9     22.7     15.8   20.5 
   U.S. West     15.8   16.8     13.3   10.5   17.2     16.3     10.6   15.7 
   Canada     15.4   17.0     17.2   17.7   12.4     13.8     11.6   27.1 
Occupational chemical exposures, %     18.9   21.1     25.1   31.2   23.7     32.5     25.5   49.3 
a All characteristics except for age are standardized to the cohort age at baseline.  
b Restricted to couples who completed the dietary questionnaire. 
c Among employed individuals. 	 	
		
114 
Table 4.2 Association between female active smoking history at baseline and fecundability 
 
 
No. of 
Cycles 
 
No. of 
Pregnancies 
Unweighted 
Unadjusted FR 
(95% CI) 
Unweighted 
Adjusteda FR 
(95% CI) 
Weighted 
Adjusteda FR 
(95% CI) 
      
Never smokers 14238 2147 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 
Former smokers   2980   389 0.88 (0.80, 0.98) 0.93 (0.84, 1.04) 0.90 (0.81, 1.00) 
Current occasional smokers     746     89 0.83 (0.67, 1.03) 0.93 (0.74, 1.16) 0.90 (0.72, 1.14) 
Current regular smokers   1107   118 0.84 (0.69, 1.02) 1.00 (0.81, 1.23) 0.98 (0.80, 1.20) 
      
Former smokers      
   Time since regular smoking (years)      
      <1     199     31 0.99 (0.69, 1.42) 1.15 (0.80, 1.66) 1.07 (0.74, 1.57) 
      1     324     44 0.95 (0.71, 1.27) 0.93 (0.70, 1.24) 0.88 (0.66, 1.18) 
      2-4     907   116 0.86 (0.72, 1.03) 0.95 (0.79, 1.13) 0.93 (0.77, 1.11) 
      ≥5   1550   198 0.86 (0.75, 0.99) 0.90 (0.78, 1.04) 0.86 (0.75, 1.00) 
   Intensity (cigarettes/day)      
      <5   1051   146 0.92 (0.78, 1.08) 0.94 (0.80, 1.10) 0.90 (0.77, 1.05) 
      5-9     764   103 0.92 (0.76, 1.11) 0.97 (0.80, 1.17) 0.92 (0.76, 1.10) 
      ≥10   1165   140 0.82 (0.70, 0.97) 0.90 (0.77, 1.06) 0.89 (0.76, 1.05) 
   Duration (years)b      
      <10   1452   207 0.91 (0.80, 1.05) 0.94 (0.82, 1.08) 0.89 (0.77, 1.02) 
      ≥10     459     64 0.86 (0.69, 1.09) 0.96 (0.76, 1.22) 0.93 (0.74, 1.16) 
   Intensity and durationb      
      <10 cigarettes/day, <10 years   1054   155 0.93 (0.79, 1.09) 0.94 (0.80, 1.10) 0.90 (0.77, 1.05) 
      ≥10 cigarettes/day, <10 years     398     52 0.87 (0.67, 1.12) 0.94 (0.73, 1.22) 0.85 (0.65, 1.10) 
      <10 cigarettes/day, ≥10 years     180     30 1.03 (0.75, 1.43) 1.13 (0.81, 1.57) 1.02 (0.73, 1.41) 
      ≥10 cigarettes/day, ≥10 years     279     34 0.75 (0.54, 1.04) 0.85 (0.61, 1.18) 0.85 (0.61, 1.19) 
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Current regular smokers      
   Intensity (cigarettes/day)      
      <5     207     28 0.98 (0.69, 1.40) 1.13 (0.79, 1.62) 1.04 (0.73, 1.48) 
      5-9     366     37 0.82 (0.59, 1.12) 0.97 (0.69, 1.34) 1.03 (0.74, 1.41) 
      ≥10     534     53 0.80 (0.61, 1.05) 0.94 (0.71, 1.25) 0.92 (0.69, 1.21) 
   Duration (years)b      
      <10     181     22 1.00 (0.67, 1.50) 1.09 (0.72, 1.65) 1.17 (0.79, 1.74) 
      ≥10     556     57 0.76 (0.59, 0.99) 0.88 (0.68, 1.16) 0.82 (0.63, 1.06) 
   Intensity and durationb      
      <10 cigarettes/day, <10 years     111     15 1.08 (0.66, 1.77) 1.21 (0.74, 1.99) 1.30 (0.80, 2.11) 
      ≥10 cigarettes/day, <10 years       70       7 0.83 (0.42, 1.64) 0.84 (0.42, 1.69) 0.95 (0.52, 1.72) 
      <10 cigarettes/day, ≥10 years     238     32 0.89 (0.64, 1.24) 1.00 (0.71, 1.41) 0.91 (0.65, 1.27) 
      ≥10 cigarettes/day, ≥10 years     318     25 0.66 (0.44, 0.98) 0.78 (0.52, 1.17) 0.73 (0.49, 1.09) 
      
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, Healthy Eating 
Index score, multivitamin or folic acid supplement use, sleep duration, PSS score, MDI score, parity, intercourse frequency, 
doing something to improve chances of conception, and current partner smoking.  
b Restricted to women age 25-34 years. 	 	
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Table 4.3 Association between female active smoking history at baseline and fecundability, stratified by menstrual 
cycles of attempt at study entry 
 Attempt time at study entry 
 0-2 cycles  3-6 cycles 
 No. of 
Cycles 
No. of 
Pregs 
Adjusted FR 
(95% CI) 
No. of 
Cycles 
No. of 
Pregs 
Adjusted FR 
(95% CI) 
       
Never smokers 9788 1578 Reference 4450 569 Reference 
Former smokers 2024   275 0.90 (0.80, 1.02)   956 114 1.04 (0.85, 1.26) 
Current occasional smokers   424     56 0.95 (0.73, 1.22)   322   33 0.86 (0.58, 1.28) 
Current regular smokers   592     62 0.95 (0.73, 1.25)   515   56 0.97 (0.68, 1.37) 
       
Former smokers       
   Time since regular smoking (years)       
      <1   139     21 1.07 (0.70, 1.65)     60   10 1.53 (0.80, 2.93) 
      1   204     26 0.83 (0.57, 1.20)   120   18 1.21 (0.77, 1.89) 
      2-4   662     84 0.93 (0.75, 1.15)   245   32 1.01 (0.70, 1.45) 
      ≥5 1019   144 0.89 (0.75, 1.04)   531   54 0.95 (0.72, 1.26) 
   Intensity (cigarettes/day)       
      <5   700   107 0.94 (0.79, 1.13)   351   39 0.94 (0.69, 1.27) 
      5-9   535     72 0.92 (0.73, 1.15)   229   31 1.11 (0.79, 1.56) 
      ≥10   789     96 0.85 (0.70, 1.03)   376   44 1.10 (0.82, 1.47) 
   Duration (years)b       
      <10 1002   148 0.91 (0.78, 1.07)   450   59 1.05 (0.81, 1.37) 
      ≥10   359     45 0.85 (0.64, 1.13)   100   19 1.56 (0.99, 2.44) 
       
Current regular smokers       
   Intensity (cigarettes/day)       
      <5   116     18 1.19 (0.76, 1.86)     91   10 0.97 (0.52, 1.80) 
      5-9   196     21 1.02 (0.67, 1.56)   170   16 0.85 (0.51, 1.39) 
      ≥10   280     23 0.77 (0.50, 1.18)   254   30 1.04 (0.72, 1.49) 
		
117 
   Duration (years)b       
      <10     70     10 1.21 (0.64, 2.27)   111   12 0.95 (0.50, 1.81) 
      ≥10   317     31 0.84 (0.58, 1.22)   239   26 0.88 (0.56, 1.37) 
       
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, Healthy Eating 
Index score, multivitamin or folic acid supplement use, sleep duration, PSS score, MDI score, parity, intercourse frequency, 
doing something to improve chances of conception, and current partner smoking.  
b Restricted to women age 25-34 years. 
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Table 4.4 Association between female active smoking history at baseline and fecundability, stratified by female age at 
baseline 
 Female age at baseline (years) 
 <30   ≥30 
 No. of 
Cycles 
No. of 
Pregs 
Adjusted FR 
(95% CI) 
No. of 
Cycles 
No. of 
Pregs 
Adjusted FR 
(95% CI) 
       
Never smokers 6754 1081 Reference 7484 1066 Reference 
Former smokers   957   135 0.89 (0.74, 1.06) 2023   254 0.95 (0.83, 1.08) 
Current occasional smokers   345     33 0.72 (0.50, 1.04)   401     56 1.08 (0.83, 1.41) 
Current regular smokers   602     69 1.01 (0.76, 1.35)   505     49 0.97 (0.71, 1.34) 
       
Former smokers       
   Time since regular smoking (years)       
      <1     96     11 0.78 (0.40, 1.53)   103     20 1.54 (1.02, 2.31) 
      1   143     22 0.92 (0.60, 1.40)   181     22 0.88 (0.59, 1.31) 
      2-4   427     61 0.92 (0.72, 1.18)   480     55 0.94 (0.73, 1.22) 
      ≥5   291     41 0.85 (0.62, 1.15) 1257   157 0.92 (0.78, 1.08) 
   Intensity (cigarettes/day)       
      <5   358     55 0.92 (0.72, 1.19)   693   91 0.94 (0.77, 1.14) 
      5-9   253     34 0.91 (0.65, 1.28)   511   69 0.99 (0.78, 1.24) 
      ≥10   346     46 0.82 (0.62, 1.10)   819   94 0.93 (0.77, 1.14) 
   Duration (years)b       
      <10   713   100 0.88 (0.72, 1.08)   739   107 0.99 (0.82, 1.20) 
      ≥10   106     18 1.09 (0.70, 1.68)   353     46 0.90 (0.68, 1.21) 
       
Current regular smokers       
   Intensity (cigarettes/day)       
      <5   115     18 1.27 (0.80, 2.01)     92     10 0.95 (0.47, 1.90) 
      5-9   203     22 1.06 (0.68, 1.64)   163     15 0.86 (0.51, 1.47) 
      ≥10   284     29 0.85 (0.57, 1.27)   250     24 1.07 (0.68, 1.68) 
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   Duration (years)b       
      <10   137     19 1.24 (0.79, 1.95)     44       3 0.77 (0.26, 2.30) 
      ≥10   239     25 0.88 (0.58, 1.33)   307     32 0.90 (0.62, 2.30) 
       
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, Healthy Eating 
Index score, multivitamin or folic acid supplement use, sleep duration, PSS score, MDI score, parity, intercourse frequency, 
doing something to improve chances of conception, and current partner smoking.  
b Restricted to women age 25-34 years. 
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Table 4.5 Exposure to passive smoking and fecundability among female never smokers 
 No. of 
Cycles 
No. of 
Pregs 
Unadjusted FR 
(95% CI) 
Adjusteda FR 
(95% CI) 
     
Current passive smoke exposure     
   None 13566 2071 Reference Reference 
   Any     672     76 0.80 (0.64, 1.01) 0.94 (0.74, 1.19) 
Current passive smoke exposure, partner smoking   
   None, partner not regular smoker 13043 2007 Reference Reference 
   Any, partner not regular smokerb     387     53 0.98 (0.74, 1.30) 1.10 (0.81, 1.49) 
   None, partner is regular smokerc     523     64 0.87 (0.69, 1.11) 0.96 (0.75, 1.22) 
   Any, partner is regular smoker     285     23 0.56 (0.36, 0.87) 0.69 (0.45, 1.06) 
Lifetime passive smoke exposure     
   Age 0-10 years   3966   569 1.04 (0.92, 1.17) 1.07 (0.94, 1.21) 
   Age 11-20 years   2957   399 0.91 (0.79, 1.05) 0.97 (0.84, 1.13) 
   Age >20   1783   227 0.96 (0.80, 1.14) 1.02 (0.86, 1.22) 
   Current     672     76 0.84 (0.65, 1.08) 0.92 (0.71, 1.19) 
In utero smoke exposure     
   None 12321 1840 Reference Reference 
   <10 cigs/day   1647   290 1.09 (0.96, 1.24) 1.19 (1.05, 1.35) 
   ≥10 cigs/day     270     27 0.66 (0.46, 0.94) 0.79 (0.55, 1.13) 
     
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, Healthy Eating 
Index score, multivitamin or folic acid supplement use, sleep duration, PSS score, MDI score, parity, intercourse frequency, 
and doing something to improve chances of conception. 
b Women who reported passive smoke exposure, but whose partner is not a regular smoker. 
c Women who reported no passive smoke exposure, but whose partner is a regular smoker. 
  
		
121 
Table 4.6 Association between male active smoking history at baseline and 
fecundability 
 No. of 
Cycles 
No. of 
Pregs 
Unadjusted FR 
(95% CI) 
Adjusteda FR 
(95% CI) 
     
Never smokers 3702 569 1.00 (Reference) 1.00 (Reference) 
Former smokers   868 158 1.15 (0.98, 1.35) 1.23 (1.02, 1.47) 
Current occasional smokers   351   40 0.80 (0.60, 1.08) 0.90 (0.65, 1.23) 
Current regular smokers   343   38 0.77 (0.56, 1.05) 0.86 (0.57, 1.29) 
     
Former smokers     
   Time since regular smoking (years)    
      <1     58   13 1.28 (0.80, 2.07) 1.70 (0.98, 2.97) 
      1     94   17 1.05 (0.66, 1.68) 1.01 (0.60, 1.71) 
      2-4   271   48 1.13 (0.86, 1.48) 1.15 (0.86, 1.52) 
      ≥5   445   80 1.16 (0.94, 1.43) 1.29 (1.03, 1.62) 
   Intensity (cigarettes/day)     
      <5   247   43 1.12 (0.85, 1.48) 1.10 (0.85, 1.42) 
      5-9   218   36 1.10 (0.81, 1.49) 1.21 (0.85, 1.72) 
      ≥10   403   79 1.18 (0.95, 1.46) 1.24 (0.93, 1.65) 
   Duration (years)b     
      <10   360   72 1.21 (0.97, 1.51) 1.27 (1.00, 1.62) 
      ≥10   145   29 1.20 (0.86, 1.67) 1.40 (0.97, 2.03) 
   Intensity and durationb     
      <10 cigs/day, <10 years   250   44 1.08 (0.82, 1.42) 1.12 (0.86, 1.47) 
      ≥10 cigs/day, <10 years   110   28 1.54 (1.11, 2.15) 1.38 (0.89, 2.15) 
      <10 cigs/day, ≥10 years     45   10 1.60 (0.94, 2.72) 1.79 (0.80, 4.00) 
      ≥10 cigs/day, ≥10 years   100   19 1.07 (0.71, 1.60) 1.21 (0.79, 1.86) 
     
Current regular smokers     
   Intensity (cigarettes/day)     
      <5     29     7 1.35 (0.69, 2.65) 1.41 (0.68, 2.92) 
      5-9     76     9 0.72 (0.38, 1.37) 0.81 (0.39, 1.65) 
      ≥10   238   22 0.70 (0.46, 1.06) 0.76 (0.46, 1.25) 
   Duration (years)b     
      <10     22     1 0.54 (0.11, 2.66) 0.58 (0.11, 3.09) 
      ≥10   173   17 0.67 (0.41, 1.07) 0.80 (0.45, 1.43) 
     
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-
sweetened beverage intake, alcohol intake, multivitamin or folic acid supplement use, 
sleep duration, PSS score, MDI score, ever impregnated female partner, intercourse 
frequency, doing something to improve chances of conception, and female partner 
smoking history, age, BMI, and education.   
b Restricted to men age 25-34 years.  
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Table 4.7 Male and female report of male current active smoking intensity 
 Male Report, n (%)a 
 
Female 
Report 
Not 
current 
<1 
cigarette/day 
1-4 
cigarettes/day 
5-9 
cigarettes/day 
≥10 
cigarettes/day 
    
   Not current 
1113 
(96.4) 
(98.6) 
41 
(3.6) 
(53.3) 
0 
(0.0) 
(0.0) 
1 
(0.1) 
(5.9) 
0 
(0.0) 
(0.0) 
 
    
   <1 
cigarette/day 
14 
(23.3) 
(1.2) 
34 
(56.7) 
(44.2) 
5 
(8.3) 
(50.0) 
3 
(5.0) 
(17.7) 
4 
(6.7) 
(8.2) 
 
    
   1-4 
cigarettes/day 
1 
(7.7) 
(0.1) 
1 
(7.7) 
(1.3) 
3 
(23.1) 
(30.0) 
4 
(30.8) 
(23.5) 
4 
(30.8) 
(8.2) 
 
    
   5-9 
cigarettes/day 
1 
(6.3) 
(0.1) 
1 
(6.3) 
(1.3) 
2 
(12.5) 
(20.0) 
6 
(37.5) 
(35.3) 
6 
(37.5) 
(12.2) 
 
   
   ≥10 
cigarettes/day 
0 
(0.0) 
(0.0) 
0 
(0.0) 
(0.0) 
0 
(0.0) 
(0.0) 
3 
(7.9) 
(17.7) 
35 
(92.1) 
(71.4) 
a N is listed first, followed by percentages in parentheses (first row, then column 
percentages). 
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Table 4.8 Association between current male active smoking and fecundability 
 No. of 
Cycles 
No. of 
Pregs 
Unadjusted FR 
(95% CI) 
Adjusteda FR 
(95% CI) 
     
Male report (n=1,282)     
   Not current smokers   3702 569 1.00 (Reference) 1.00 (Reference) 
   Current occasional smokers     351   40 0.78 (0.58, 1.05) 0.82 (0.60, 1.12) 
   Current regular smokers     343   38 0.74 (0.54, 1.01) 0.86 (0.59, 1.24) 
      Intensity (cigarettes/day)     
         <5       26     7 1.33 (0.68, 2.61) 1.32 (0.60, 2.90) 
         5-9       71     8 0.70 (0.37, 1.33) 0.84 (0.42, 1.66) 
         ≥10     194   22 0.67 (0.44, 1.01) 0.77 (0.48, 1.24) 
     
Female report (n=1,282)b     
   Not current smokers   3877 591 1.00 (Reference) 1.00 (Reference) 
   Current occasional smokers     208   25 0.91 (0.67, 1.25) 1.01 (0.73, 1.39) 
   Current regular smokers     311   31 0.69 (0.49, 0.96) 0.74 (0.50, 1.09) 
      Intensity (cigarettes/day)     
         <5       62     6 0.55 (0.26, 1.15) 0.60 (0.28, 1.28) 
         5-9       72     8 0.84 (0.45, 1.56) 0.97 (0.51, 1.88) 
         ≥10     175   17 0.68 (0.43, 1.08) 0.71 (0.42, 1.21) 
     
Female report (n=4,830)b     
   Not current smokers 15945 2387 1.00 (Reference) 1.00 (Reference) 
   Current occasional smokers   1061   136 0.88 (0.74, 1.03) 0.92 (0.78, 1.08) 
   Current regular smokers   2065   220 0.80 (0.70, 0.91) 0.87 (0.76, 1.01) 
      Intensity (cigarettes/day)     
         <5     388     40 0.69 (0.52, 0.93) 0.75 (0.55, 1.01) 
         5-9     506     61 0.93 (0.71, 1.23) 1.04 (0.79, 1.35) 
         ≥10   1119   113 0.76 (0.63, 0.93) 0.83 (0.68, 1.03) 
     
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-
sweetened beverage intake, alcohol intake, multivitamin or folic acid supplement use, 
sleep duration, PSS score, MDI score, ever impregnated female partner, intercourse 
frequency, doing something to improve chances of conception, and female partner 
smoking history, age, BMI, and education.  
b Adjusted for age, education, female race/ethnicity, annual household income, BMI, 
female parity, intercourse frequency, doing something to improve chances of conception, 
and female partner smoking history, age, BMI, and education. 
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Table 4.9 Exposure to passive smoking and fecundability among male never smokers 
 No. of 
Cycles 
No. of 
Pregs 
Unadjusted FR 
(95% CI) 
Adjusted FR 
(95% CI) 
     
Current passive smoke exposure     
   None 3438 519 Reference Reference 
   Any   264   50 1.07 (0.67, 1.70) 1.09 (0.74, 1.61) 
Current passive smoke exposure, partner smoking   
   None, partner not regular smoker 3388 513 Reference Reference 
   Any, partner not regular smoker   243   48 1.10 (0.70, 1.71) 1.09 (0.79, 1.50) 
   None, partner is regular smoker     50     6 1.00 (0.48, 2.06) 1.11 (0.77, 1.59) 
   Any, partner is regular smoker     21     2 0.71 (0.15, 3.38) 0.93 (0.44, 1.97) 
Lifetime passive smoke exposure     
   Age 0-10 years 1025 164 0.99 (0.69, 1.44) 0.99 (0.76, 1.30) 
   Age 11-20 years   824 120 0.99 (0.68, 1.44) 1.05 (0.74, 1.49) 
   Age >20 years   728   97 0.92 (0.65, 1.31) 0.95 (0.73, 1.23) 
   Current   264   50 1.13 (0.70, 1.80) 1.07 (0.69, 1.66) 
     
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, alcohol intake, 
multivitamin or folic acid supplement use, sleep duration, PSS-10 score, MDI score, ever impregnated female partner, 
intercourse frequency, doing something to improve chances of conception, and female partner smoking history, age, BMI, and 
education. 
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Table 4.10 Lifetime exposure to active and passive smoking among female and male pregnancy planners 
 Female (n=4,830)  Male (n=1,282) 
Exposure No. of Pregnancies 
No. of 
Cycles 
Adjusted FR  
(95% CI)  
No. of 
Pregnancies 
No. of 
Cycles 
Adjusted FR  
(95% CI) 
No early passive, no adult passive, 
never active 1392 9034 1.00 (Reference)  352 2214 1.00 (Reference) 
No early passive, no adult passive, 
past active   185 1156 1.06 (0.92, 1.22)    75   397 1.27 (0.94, 1.72) 
No early passive, no adult passive, 
current active     19   163 0.88 (0.56, 1.37)    14     83 0.96 (0.44, 2.10) 
No early passive, adult passive, 
never active   111   913 0.95 (0.78, 1.16)    50   467 0.93 (0.59, 1.47) 
No early passive, adult passive, past 
active     73   552 0.97 (0.78, 1.20)    24   163 1.02 (0.66, 1.57) 
No early passive, adult passive, 
current active     17   197 0.86 (0.53, 1.40)      4     65 0.82 (0.24, 2.86) 
Early passive, no adult passive, 
never active   533 3416 1.10 (1.00, 1.21)  122   796 1.03 (0.81, 1.32) 
Early passive, no adult passive, past 
active   106   946 0.89 (0.72, 1.10)    43   204 1.45 (1.05, 2.01) 
Early passive, no adult passive, 
current active     28   156 1.35 (0.93, 1.97)      5     48 0.86 (0.32, 2.32) 
Early passive, adult passive, never 
active   133 1092 1.05 (0.85, 1.29)    64   386 1.08 (0.76, 1.53) 
Early passive, adult passive, past 
active     92   855 0.81 (0.65, 1.02)    37   294 1.00 (0.65, 1.53) 
Early passive, adult passive, current 
active     54   591 0.94 (0.69, 1.28)    15   147 1.04 (0.55, 1.97) 
a Adjusted for age, race/ethnicity, education, annual household income, BMI, sugar-sweetened beverage intake, Healthy Eating 
Index score, multivitamin or folic acid supplement use, sleep duration, PSS score, MDI score, parity, intercourse frequency, 
and doing something to improve chances of conception. 
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Figure 4.1 Directed acyclic graph of the relationship between smoking and fecundability 
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5 CONCLUSION 
 In this dissertation, we examined the association between three environmental and 
psychosocial exposures and fertility in two different cohorts.  In the Cape Cod Family 
Health Study, we studied residential exposure to tetrachloroethylene (PCE) in relation to 
time to pregnancy (TTP) among women who gave birth on Cape Cod from 1969-1983.  
In Pregnancy Study Online (PRESTO), we studied perceived stress and active and 
passive smoking in relation to fecundability among female and male pregnancy planners 
from the United States and Canada.  Overall, we found some evidence of an association 
between all three exposures and lower fertility; however, associations were weak. 
 In the first study, we found evidence that high levels of PCE exposure around the 
time of conception, but not long-term exposure, were associated with slightly longer 
TTP.  We examined this association in a retrospective cohort of Cape Cod women who 
were exposed to PCE through contaminated drinking water.1  Because all women in the 
cohort gave birth, and we only had information on TTP for pregnancy attempts that 
resulted in a clinical pregnancy, our results are likely underestimates.  In addition, 
outcome assessment was based on long-term recall of TTP, and exposure assessment was 
based on a leaching and transport model for the amount of water that entered the 
residence annually.2  Both of these measures are subject to non-differential 
misclassification, which may have resulted in bias towards the null in the extreme 
exposure categories.  Although unmeasured confounding by demographic, behavioral, or 
medical factors is unlikely, residual confounding by time is possible, given that the study 
occurred over many years and time is strongly correlated with exposure and outcome.  
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Despite these limitations, however, the contamination of drinking water on Cape Cod 
represents a unique exposure scenario in which to examine the association between 
residential PCE exposure and TTP.  Most of the available evidence on PCE exposure and 
reproductive health comes from occupational cohort studies3-9 where the intensity and 
sources of exposure are different from the present study. 
 In the second study, we examined the association between perceived stress and 
fecundability among female and male pregnancy planners in a preconception cohort 
study.10  We observed a lower fecundability among female, but not male, pregnancy 
planners with the highest levels of perceived stress at baseline.  We measured female 
perceived stress prospectively throughout the conception attempt time and found similar 
results for baseline, time-varying, and cumulative average stress levels.  We found little 
evidence for strong mediating effects by several behavioral variables including smoking 
and sleep.  We corrected for differential loss to follow-up using inverse probability of 
continuation weights.  Although we were unable to measure stress at a more granular 
level (e.g., during the ovulatory window), as other studies have done,11-13 we used a well-
validated measure of stress over the past four weeks.14   
In the third study, we examined the relation of female and male active and passive 
smoking with fecundability.  Despite substantial evidence in the literature and a 
conclusion from the Surgeon General’s Report of the Health Consequences of Smoking 
that female active smoking causes infertility,15 we observed only small reductions in 
fecundability among the heaviest female smokers.  On the other hand, we found 
consistently lower fecundability among male current smokers compared with never 
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smokers.  There are three potential explanations for the inconsistency between our female 
results and other studies.  First, the intensity of smoking has declined over time in North 
America,16 and we may not have had enough heavy smokers in our cohort to observe an 
association, in particular if smoking is only causally related to fertility at high intensities.  
Second, we were able to control for a wide range of potential confounders and observed 
substantial attenuation of our results in adjusted models, suggesting that other studies 
with limited confounder control may be biased.  Lastly, our results could be due to 
chance.  However, our results are likely not due to differential loss to follow-up or under-
reporting of smoking, as we assessed these sources of bias in our analysis.  
In conclusion, we observed weak associations between PCE exposure, perceived 
stress, and active smoking and fertility among pregnancy planners.  These findings 
indicate that environmental and psychosocial factors may play a role in the etiology of 
infertility. 
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